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Abstract 
RNA-binding proteins (RBPs) are important for a wide variety of biological 
processes involved in gene regulation. However, the structural and dynamic contributions 
to their biological activity are poorly understood. The tristetraprolin (TTP) family of 
RBPs, including TTP, TIS11b and TIS11d, regulate the stability of mRNA transcripts 
encoding for key cancer-related proteins, such as tumor necrosis factor- and vascular 
endothelial growth factor. Biophysical studies have shown that the RNA binding domain, 
consisting of two CCCH zinc fingers (ZFs), is folded in the absence of RNA in TIS11d 
and TIS11b. In TTP, however, only ZF1 adopts a stable fold, while RNA is required to 
completely fold the tandem zinc finger (TZF). The focus of this research was to 
understand the origin and biological significance of the structural differences observed 
for the TZF domains of TTP and TIS11d. Three residues were shown to control the 
affinity for the structural Zn2+ and determine the folding of ZF2 in the absence of RNA.  
The partially-folded TZF domain of TTP has greater selectivity for RNA sequences than 
the fully folded TZF domain of TIS11d. The mRNA destabilizing activity of TTP was 
increased when the partially disordered RBD of TTP was replaced with the fully 
structured TZF domain of TIS11d. Disruption of the structure and/or dynamics of the 
TZF domain observed in the disease-associated mutations of TIS11d, P190L and D219E, 
results in aberrant cytoplasmic localization. This work demonstrates that the extent of 
RBD folding in the TTP family is important for differential RNA recognition, mRNA 
turnover, and protein localization in vivo. 
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Chapter I: Introduction 
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The eukaryotic cell needs to rapidly modify the expression levels of many 
proteins in response to cues from the extracellular environment. Although traditionally 
much work has focused on transcriptional control, one major mechanism for regulating 
protein expression is through post-transcriptional regulation of their encoding mRNAs.  
This regulatory mechanism is particularly important during development when 
transcription is typically repressed1-5 and during inflammatory responses6 when multiple 
genes are coordinated rapidly in response to external cues.  During these processes, 
RNA-binding proteins (RBPs) function to control mRNA stability, editing, localization, 
and translational efficiency 7,8. Accordingly, dysregulation of these processes causes 
multiple diseases, including amyloid lateral sclerosis (ALS)9, fragile X retardation10, 
acute inflammatory disease11 and cancer 12,13. Therefore, examining the relationship 
between the structure and function of RBPs and their cellular targets is essential for 
understanding their role in human physiology.   
Post-transcriptional gene regulation is dependent on protein and RNA structure  
Post-transcriptional regulation begins during RNA synthesis in the nucleus and 
continues through translation in the cytoplasm. Many mRNA processing steps, including 
mRNA capping, splicing, polyadenylation, and editing as well as mRNA localization and 
stability, are regulated at the post-transcriptional level through the function of RBPs14,15 
(Figure 1.1).   
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Because RBPs are the main 
facilitators of post-transcriptional 
regulation, it is imperative to understand 
how these proteins recognize and bind to 
their RNA targets.   
RBPs contain multiple structural 
motifs, such as the RNA recognition 
motifs (RRMs)16,17, double stranded 
RNA-binding domain (dsRBD)18,19, K 
Homology (KH) domains20,21, and zinc 
fingers (ZFs)22-24 (Table 1.1).  
Just as the primary amino acid 
sequence and  secondary structure of 
RBPs are important for RNA-mediated 
post-transcriptional control, so are the primary sequence integrities and folds of the target 
RNAs; most RBPs –even those among the same class of RBP domains– have  sequence 
and RNA structure preferences. For example, some proteins have high sequence specific 
requirements, such as MuscleBlind Like (MBNL)-1 CCCH protein that binds specifically 
to CUG or CCUG repeats to regulate tissue specific alternative splicing25. Additionally, 
some proteins have specific RNA shape requirements, such as the RNA editing enzyme 
ADAR226, which is a dsRBP that binds specifically to the minor- major – minor-groove 
surface of RNA. Typically, post-transcriptional regulation is achieved through the 
Figure 3.1 Post-transcriptional Regulation is 
controlled by RBPs. A model of the eukaryotic cell. 
Post-transcriptional regulation is facilitated by RNA 
binding proteins (small circles) at many mRNA 
processing steps, including mRNA capping, splicing, 
polyadenylation and editing. Many factors remain 
associated with mRNA and are exported out of the 
nucleus into the cytoplasm to facilitate mRNA 
localization, translation and degradation.   
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interaction of RBPs to the 5′ or 3′ untranslated regions (UTRs) of the RNA27. These 
RNAs can be single or double stranded, have secondary structure, such as hairpin and 
stem loops that can interact to form tertiary structure and/or be modified via methylation, 
each of which changes the structure and biochemical properties of the RNAs28.  These 
changes can have dramatic effects on a specific RBP′s recognition and binding of the 
target RNA29.    
Table 1.1: RBPs contain multiple structural motifs 
  
Name of 
domain 
Structural description Protein-RNA interface Representative 
structure 
RRM ~90 residue polypeptide 
chain folded into two alpha 
helices and four-antiparellel 
beta-strands  
Aromatic residues stack 
specifically with ssRNA 
bases  
 
dsRBD ~70 amino acids folded 
with two alpha-helices 
packed against a three 
stranded beta-sheet.   
Shape specific 
recognition of dsRNA 
minor-major-minor 
groove patterns with 
sugar phosphate 
backbone  
KH ~70 amino acids and fold 
into three antiparallel beta 
sheets packed against three 
alpha helices  
Binds to ds/ssRNA 
through aromatic 
stacking at the cleft 
formed between the first 
and second alpha helix 
and variable loop  
ZF ~70 amino acid peptide 
chain containing minimal 
secondary structure; fold 
according to the 
coordination of three 
cystines and a histidine 
residue by a zinc ion 
ssRNA binding 
interactions occur 
through protein 
backbone and side chain 
hydrogen bond contacts 
and aromatic stacking.  
ADAR226 
NOVA220
 
MBNL125 
MSI1205 
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Post-transcriptional mRNA turnover 
 The fate of a particular mRNA is tightly regulated from transcription in the 
nucleus through translation and degradation in the cytoplasm.  In the cytoplasm, mRNAs 
can be: (1) stored in a particular sub-cellular localization,30 (2) assembled with ribosomes 
for protein synthesis31, or (3) degraded32.  One of the most important of these is mRNA 
decay, which acts as a quality control mechanism for aberrant transcripts and 
protein/mRNA levels in the cell33. Research in the last 3 decades has defined multiple 
pathways of mRNA turnover (Figure 1.2)34. Transcripts containing pre-mature stop 
codons due to incomplete splicing, transcription errors, or RNA mutations are subject to 
nonsense mediated decay35.  In this process, mRNA degradation is triggered by 5′ 
decapping, 3′ poly(A) tail removal, and cleavage by endonucleases.  All mRNA 
transcripts that pass quality control surveillance have a limited lifetime. In eukaryote 
cells, mRNA turnover occurs through deadenylated-mediated decay36.  During this 
process, the nacent poly(A) tail is first removed via one of three processes. 1) The 
poly(A)-specific ribonuclease (PARN) complex that binds directly to the 5 ̍cap of 
transcripts and removes nucleotides from its poly (A) tail. 2) The Ccr4/Caf1/Not complex 
forms a multimeric CCR4-NOT1 complex which binds to factors associated with the 
RNA. The association of CCR4-NOT1 complex with the RNA positions the CAF1 
deadenylase for poly (A) tail removal.  3) In a few cases, the Pan2/Pan3 exonuclease 
complex has been shown to be important for initial poly (A) shortening. These processes 
of deadenylation destabilizes the cap binding complex, and triggers 3′ to 5′ mRNA 
degradation via a 3′ exoribonuclease multi-protein complex called the exosome. 
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Alternatively, deadenylation can trigger Lsm1-7 protein complex binding to the 3′ end of 
the RNA leading to decapping via the Dcp1/Dcp2-complex, which in turn causes the 
degradation of the mRNA by the 5′–3′ exonuclease Xrn1 (Figure 1.2). 
 
Figure 1.2: Post-transcriptional mRNA decay mechanisms. A model of eukaryotic mRNA turnover. 
Nacent mRNAs (orange) have a 5′cap and 3′ poly (A) tail. Deadenylation by 1) the poly (A)-specific 
ribonuclease (PARN) 2) the Ccr4/Not complex or 3) the Pan2/Pan3 exonuclease initiate poly (A) 
shortening. Deadenylation triggers 3 ̍ to 5′ mRNA degradation uses a 3′exosome complex. Alternatively, 
deadenylation triggers Lsm1-7 protein complex binding to the 3′ end of the RNA which triggers the 
removal of the 5 ̍ cap of RNA by Dcp1/Dcp2-complex, which in turn causes the degradation of the mRNA 
by the 5′–3′ exonuclease Xrn1. 
 mRNA decay rates can vary substantially between mRNAs37,38. In mammalian 
cells, the average rate of decay is 8 hours; however, it can be as fast as 15 minutes (TNF-
α) or as slow as 17 hours (β-globin)39,40. One feature that controls mRNA decay is 
stability elements, short sequence elements within mRNAs that control the rate of mRNA 
turnover38. One of the most well characterized instability elements controlled post-
transcriptionally is the adenine and uracil rich sequence element (ARE) identified in 1986 
by Cerami et al. AREs are sequence elements of 50-150 nucleotides located in the 3′-
UTRs of mRNA with short half-lives41. Indeed, chimeric mRNAs containing an ARE 
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instead of their endogenous 3′-UTR have increased turnover in cells, suggesting that the 
presence of these sequence elements leads to mRNA instability (Figure 1.3)42. ARE 
motifs are enriched in essential inflammatory mediators, such as the cytokines tumor 
necrosis factor (TNF)-α and interleukin (IL)-1α/ β, the lymphokine granulocyte-
macrophage colony stimulating factor (GM-CSF), highlighting the role these motifs play 
in transient biological processes41,43,44.  
 
Recent computational analysis estimates that 8% of human transcripts contain 
AREs45.  In fact, AREs are also found in many oncogenes, such as c-fos, COX-2, and c-
myc. Mutation of the single ARE in c-fos does not decrease the ARE′s ability to 
destabilize the mRNA, suggesting that the ARE motif is essential for only a subset of 
transcripts46. Later studies showed that the stability of the ARE of the 3′ UTR is governed 
through a host of RBPs (more than 20, including TTP) to either promote or inhibit the 
Figure 1.3: AREs controls mRNA decay. Schematic representation of the effects of the adenine-
uridine rich stability element (ARE), short sequence elements (blue) within mRNAs that control the 
rate of mRNA turnover. ARE elements are located at the 3׳ UTR of the TNF-α mRNA (orange) which 
trigger its fast deadenylation proceded with rapid degradation. β globin mRNAs (purple) are long lived 
(lifetime of 17 hours). Chimeras which replace β globin 3׳ UTR with that of TNF-α rapidly degrade, 
indicating that it is the ARE feature on mRNA that dictates turnover42.  
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ARE degradation machinery or influence their cellular localization47. Interestingly, the 
RBD of these post-transcriptional regulators have different folds and binding site 
preferences (Table 1.2). 
Table 1.2: ARE binding proteins function, fold, and binding site preference  
Protein family 
Function in 
mRNA 
metabolism 
Fold Binding site 
ELAV/Hu 
family 
Stabilize RRM U and CU-rich sequences48,49 
TTP family Destabilize CCCH UUAUUUAUU50 
HRNPD/AUF1 
family 
Stabilize RRM 
AUGUAUUGUUUAUACAU 
(hairpin)51 
TIA1/TIAR 
translational 
repressors 
RRM uridylate stretches52 
KSRP 
mRNA splicing/ 
destabilizing 
KH low sequence specificity53 
 Many of these ARE binding proteins compete for the same RNA sequence. For 
example, Growth Associated Protein (GAP)-34 is a protein in the cell that controls axonal 
outgrowth. KSRP binds to GAP-43 ARE mRNA to promote its decay in cells, while HuD 
binds to and stabilizes this same mRNA. Given their antagonistic behavior, much work 
has been done to investigate the competition between these proteins for ARE 3 ̍ UTRs. 
Competition binding experiments have shown that HuD binds to the mRNA with a lower 
affinity than KSRP. This results in the displacement of HuD upon KSRP overexpression 
and subsequently leads to in an inhibition of axonal outgrowth. This example highlights 
how the complex network of interactions between RBPs must be explored in order to 
fully understand how these proteins regulate their mRNA targets in vivo54.  
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Tristetraprolin  
 Of the many proteins that bind to AREs at 3′ UTRs, the most well characterized is 
tristetraprolin (TTP). TTP was originally identified as an early response gene whose 
expression is induced in response to many different stimuli, such as the pro-/anti- 
inflammatory factors TNF-α55, IL-1β56, and lipopolysaccharide (LPS)57. The role of TTP 
was first identified in a study involving the early expression of genes in 3T3 fibroblasts 
after treatment with insulin. The Blackshear group found that after exposing these cells 
for ten minutes to insulin, an increase in transcription levels was observed corresponding 
to the biogenesis of 25 proteins58. Of the transcripts sequenced, only one had a unique 
protein sequence, which contained 3 groups of 4 consecutive proline rich patches. They 
coined this early response gene “Tristetraprolin” (TTP).  Since then TTP has been noted 
for its regulation of the short lived mRNA encoding the inflammatory cytokine, TNF-α.  
Early studies demonstrated that TTP-deficient mice suffer from systematic inflammatory 
syndrome, due to over-expression of TNF-α. Increased TNF-α concentrations seem to be 
directly linked to inflammatory syndrome in mice since symptoms are alleviated if TTP-
deficient mice are injected with antibodies specific for TNF-α. Directed truncation 
experiments of the coding and noncoding sequences of TNF-α map TTPs binding to its 
3′UTR highlighting a mechanism by which loss of TTP-mediated gene regulation can 
lead to chronic inflammatory diseases59. 
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TTP mRNA decay is controlled through the recruitment of multimeric 
polyadenylation decay enzymes  
Tristetraprolin acts to limit cytokine toxicity by initiating mRNA decay through 
direct interactions between its N- and C- terminal domains and various deadenylases 
(Figure 1.4)60. Truncation and coimmunoprecipitation assays have determined that TTP 
associates with many of the known multimeric mRNA decay pathway enzymes, 
highlighted above60. Specifically, the Ccr4/Caf1/Not complex is recruited through an 
interaction between the conserved C-terminus of TTP with NOT161. Recently, a C-
terminal peptide of TTP, comprised of residues 312-326, was crystallized with the CCR4-
NOT1 complex62. Although only a small fragment of the TTP sequence, mutations in this 
region of full-length TTP result in impaired RNA decay, further demonstrating CCR4-
NOT1 interaction with the TTP family. However, this function of TTP (interactions with 
mRNA decay machinery) is tightly controlled through its mRNA/protein expression, 
phosphorylation, and subcellular localization as discussed below.  
 
 
 
 
 
 
 
Figure 1.4: TTP is an RBP that 
facilitates rapid mRNA decay. A 
model of mRNA degradation initiated 
by TTP binding to ARE-containing 
mRNA. Binding of TTP promotes 
degradation of the mRNA transcripts, 
thus decreasing protein production of 
TNF-α.  
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Regulation of the post-transcriptional regulator TTP 
TTP controlled expression 
 In normally cultured fibroblast cells, TTP gene expression is low to undetectable 
and the protein is localized predominantly in the nucleus63. Transcription and subsequent 
translation of TTP can be induced when cells are exposed to stimuli, such as LPS57. LPS 
exposure activates the mitogen activated protein kinase (MAP-Kinase) family, initiating a 
cascade of signaling events to activate transcription factors specific for the rapid 
accumulation of mRNA encoding TTP57. TTP mRNA overexpression is seen as early as 
15 minutes and basal levels are achieved within 2 hours after cells are stimulated64. This 
overexpression of TTP is necessary to prevent cellular damage from the toxic 
accumulation of cytokines.  
TTP activity is spatiotemporally regulated  
TTP ̍s ability to target transcripts for rapid cytoplasmic degradation is positively 
regulated via its phosphorylation, specifically at residues S60 and S186 by MAPK-AP 
kinase-2 (MK2)65. Although mass spectroscopy has determined that both S60 and S186 
are phosphorylated by MK2, binding assays demonstrate that phosphorylation of only 
S186 is critical for TTP association with the adapter protein 14-3-3. This interaction is 
necessary for the TTP/RNA complex translocation into processing bodies (P-bodies), the 
site of mRNA degradation, as the14-3-3 acts as a chaperone to protect TTP from 
proteasomal degradation. Mutant S60A TTP has a moderate effect on 14-3-3 association, 
while mutant S186A completely abrogates binding to 14-3-3 adaptor protein.  TTP ̍s 
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interaction with the dimeric face of the 14-3-3 proteins is thought to preclude CAF1 
association of the CCR4-CAF1-NOT1 complex for mRNA deadenylation and subsequent 
degradation. Therefore, in its phosphorylated state, TTP is rendered inactive for mRNA 
decay. Additional evidence suggests that the phosphorylation of TTP also decreases it 
relative affinity for the ARE sequence (Figure 1.5)66.  
 
Figure 1.5: Phosphorylation regulates TTP activity in the cell. In TTP unphosphorylated state it binds to 
the 3’UTR of mRNA at the ARE for the rapid turnover of transcripts. Phosphorylation of TTP by MAPK-
AP kinase-2 (MK2) allows for 14-3-3 adaptor protein association prevents the recruitment of degradation 
enzymes recruited by TTP. TTP is activated upon dephosphorylating by protein phosphatase 2A (PP2A). 
Phosphorylation of TTP also influences its subcellular localization (red text). 
Phosphorylation is necessary for the temporal and spatial regulation of TTP in 
order to ensure the accurate turnover of TTP mRNA targets. Early experiments on 
fibroblast cells transfected with GFP-TTP suggested the protein was mostly nuclear67. 
When these cells are exposed to stress or an abundance of mitogens, such as LPS, TTP 
was seen to be translocated into the cytoplasm. Further evidence that TTP is a 
nucleocytoplasmic shuttling protein came with the identification of the N- terminal 
LxxxLxxLxL sequence that is characteristic of a nuclear export signal (NES)68. The nuclear 
export receptor Exportin 1 (XPO1), also known as chromosomal maintenance 1 (CRM-
1), is responsible for binding to this sequence on TTP for it proper translocation out of 
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the nucleus69to subcellular foci containing mRNA decay enzymes. A separate study was 
done to map the nuclear localization sequence (NLS) of TTP. In this study, two basic 
residues, R134 and R137 of TTP RBD were shown to be critical for its association with 
Importin α/β70. Mutations of these arginines to alanines results in the mislocalization of 
TTP. Importin’s association with the TTP/RNA complex suggests that TTP RNA binding 
may be required for its proper translocation into the cytoplasm. mRNA turnover occurs 
mainly in the cytoplasm and changing TTP′s primary sequence results in its 
mislocalization into cytoplasmic foci, suggesting RNA binding may provide another 
mechanism by which cells regulate TTP activity.   
Alternative spatiotemporal regulation of TTP occurs in response to cellular stress 
(Figure 1.5). Under these conditions, unphosphorylated TTP colocalizes with ARE 
transcripts, forming transient foci in the cytoplasm called stress granules32. Stress 
granules are thought to sequester TTP from RNA decay enzymes, thereby providing 
another level of regulation of TTP′s activity in the cell. Only when TTP is 
phosphorylated is it excluded from stress granules and released into the site of mRNA 
turnover, P-bodies71,72. The interplay between RNA binding, phosphorylation, and 
subcellular localization is critical for TTP’s function to keep the concentration of 
cytokines, such as TNF-α, low in the cell.  
TTP and cancer 
As described above, TTP activity is coordinated through multiple processes to 
regulate gene expression in order to control normal cellular homeostasis. Dysregulation 
of TTP at any of these steps has the potential to cause cancer in addition to chronic 
 
 
 14 
inflammation, as TTP binds to many critical ARE-rich containing genes aberrantly 
overexpressed in cancer (Table 1.3). Many immortalized cancer cell lines (brain, breast, 
liver, colon, cervix) and tumors of the lung, ovary, prostrate, and thyroid have been 
shown to have decreased expression levels of TTP73. In fact, decreased TTP gene 
expression is now known to be a common prognostic indicator for breast cancer74.  
Other studies demonstrate that TTP plays a role in suppressing factors that 
promote vascularization that lead to tumorigenesis. TTP-knockout mice injected with 
cells containing TTP under control of an inducible promoter formed large tumors when 
TTP was not expressed.  However, when TTP expression was induced with doxycycline, 
tumor size was reduced significantly.  Furthermore, vascular endothelial growth factor 
(VEGF) protein levels in these tumor cells decreased in response to increasing TTP gene 
expression. Decreased VEGF levels, resulted in tumors with diminished 
vascularization100. Presenting TTP as a tumor suppressor protein resulted in a multitude 
of experiments to identify more cancer related mRNA targets (Table 1.2).  
TTP loss-of-function mutations and their profound physiological effects on 
disease manifestation and progression have opened up the characterization of the entire 
TTP family, which includes TIS11d and TIS11b. Mutations in TIS11d and TIS11b have 
also been associated with the pathogenesis of certain types of human cancers101,102. 
Frameshift and point mutations throughout the TIS11d gene locus have been identified in 
tissues taken from leukemia patients103. In 2010, Hodson et al. identified Notch1 as a 
direct target of TIS11d and TIS11b104. Additionally, the angiogenic gene DII4 is the only 
known in vivo target of TIS11b105. The critical involvement of TIS11d and TIS11b in 
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cancer progression motivates detailed analysis to understand how these RNA-binding 
proteins recognize and bind to their particular mRNA transcripts. 
Table 1.3 Reported mRNA targets of TTP  
Reported gene target References Cellular Process 
TNF-α                        55 Inflammation/Cancer 
GM-CSF                    75 
IL-2, IL-10 IL3, IL-6, IL-12                76,77
Ier3                            78 
Polo-like kinase 3   79 
Ccl2/3                         80 
CD86                          81 
c-fos                           82 
cIAPs                               83 
c-myc                               84 
COX-2                               85 
DUSP1                             86 
E6-AP                                87 
E47                                     88 
IDO                                    86 
IFN-gamma                         89 
iNOS                                   90 
LATS2                               91 
MHC (Class 1B and F)      86 
MMP-1 92 
PAI type 2 93 
TTP 94  
uPA 92 
uPAR 92 
VEGF 95 
Cyclin D1                            84 Cell cycle 
MIP-2 96 
p21 82 
1,4-galactosyltransferase 97 Other 
PITX2 98 
*Targets in bold are classified as "physiological" targets - confirmed through assays 
with cells from knock-out mice. Genome wide analysis through microarray 98, 
(RIP)-Chip77, and (PAR-Clip)99 have also identified 250, 137, and 1,313 TTP mRNA 
targets, respectively. 
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TTP family members are not redundant 
TTP family members, TIS11b and TIS11d were identified though tetradecanoyl 
phorbol acetate- (TPA-) induced expression in fibroblast cells in 1991106.  TIS11b and 
TIS11d have TTP-like activity and bind to ARE-rich sequence elements in the 3′UTR of 
TNF-α, causing rapid deadenylation and triggering mRNA decay107. The fact that they all 
are located on different chromosomes; TTP chromosome 19q13.1, TIS11b chromosome 
14q22-24, and TIS11d chromosome 2p22.3-p21, suggests that these proteins may be 
redundant108. However, TTP, TIS11b, and TIS11d knockout mice exhibit different 
phenotypes, suggesting these proteins cannot replace each other’s function.  Additionally, 
mRNA expression patterns of TTP, TIS11b, and TIS11d are different109-111. Where TTP 
mRNA expression is greatest in cervical tissue, TIS11b and TIS11d mRNA expression is 
greatest in the pancreas and thymus112. Therefore although TTP, TIS11b, and TIS11d 
perform the same function by operating to facilitate mRNA degradation, their different 
transcriptional regulation and the differences in their tissue specific expression suggests 
that they regulate different mRNA targets (Table 1.4).     
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Table 1.4: Summary of phenotypes observed in TTP family knockout mice  
TTP family 
member 
Phenotype of knockout mice 
TTP 
Death within 7-16 months as a result of systemic inflammatory 
syndrome 
TIS11b 
Embryonic  lethality from  embryonic vascular abnormalities and 
heart defects 
TIS11d 
Survive for approximately 2 weeks after birth, but suddenly die as a 
result defective hematopoiesis 
 
Sequence alignments of TTP with its family members, TIS11d and TIS11b, show 
the highest sequence similarity at their CCCH tandem zinc finger (TZF)  with TIS11d 
and TIS11b being 71% identical to TTP and 91% identical to each other, with most 
variations found in the N- and C-terminal domains (Figure 1.6)113.  The minimal RNA 
binding unit of TTP was mapped through truncation experiments to contain the 72 amino 
acid (residues 102-174) CCCH tandem zinc finger (TZF) motif. The conservation of the 
CCCH motif therefore identified the RBD of TIS11d and TIS11b as well.  Both the N- 
and C-terminal domains are necessary for the recruitment of enzymes essential for 
mRNA degradation and regulation of TTP activity though phosphorylation and 
localization108. Primary sequence predictions on the N-terminal and C-terminal domains 
determine that these domains are intrinsically disordered114. Given the high sequence 
conservation of the RNA-binding domains of TTP and TIS11 proteins, structural studies 
would help elucidate how these proteins recognize and bind distinct mRNAs, targeting 
them for mRNA decay.  
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Figure 1.6: Sequence alignment of the human TTP family members. Identical residues (*), conserved 
(:) and semi-conserved (.) residues are denoted below each line of the alignment. 
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Differences in RNA binding for TIS11d and TTP are observed through NMR 
Heteronuclear single quantum coherence (HSQC) spectra are the most common 
nuclear magnetic resonance (NMR) approach to observe changes in the secondary 
structure of proteins upon addition of substrate. This NMR experiment allows scientists 
to correlate the chemical shifts of covalently bond nuclei, often 15N and 1H, through 
measuring the direct transfer of magnetization from the proton to the bound amide 
nitrogen. The correlation of each amide 15N and 1H can be plotted to generate a two 
dimensional spectrum, where each amide peak, with the exception of proline, which does 
not have an amide group, can be assigned. HSQC experiments can provide information 
regarding whether a protein is folded, a molten globule, or unfolded115. Proteins that are 
well folded are characterized as having well dispersed and sharp peaks of every amino 
acid, whereas unfolded proteins give a signature of sharp, overlapping peaks at the 8 ppm 
region of the spectrum due to all amide protons being equally solvent exposed and 
sharing a similar chemical environment. A highly dynamic/flexible, molten globular 
protein spectrum shows significant line broadening of signals, and these cross peaks are 
not visible in the HSQC. 
 The HSQC spectrum of the TZF domain (100-174) of TTP has been published116.  
In this structure, only the amino terminal zinc finger and linker were clearly resolved and 
all cross peaks from its C- terminal zinc finger are missing, indicating that this region 
samples an ensemble of states and as consequence cross peaks are broadened beyond the 
detection limit. However, with the addition of RNA (5′UUUUAUUUAUUUU′3) cross-
peaks were observed in the spectra that correspond to residues in the linker and zinc 
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finger 2 (ZF2) that were absent in the RNA-free spectra, but in the presence of zinc 
(Zn2+). The appearance of resonances from ZF2 indicates that a large conformational 
change occurs upon RNA binding, which stabilizes the second zinc finger. Taken 
together, these findings demonstrate that only the N-terminal TZF domain of TTP adopts 
a stable fold in the unbound state in the presence of zinc (Zn2+), and that RNA binding 
induces folding of ZF2 (Figure 1.7). 
 
Figure 1.7: Only the N-terminal TZF domain of TTP adopts a stable fold in its unbound state; RNA 
binding induces complete TZF fold. HSQC spectra of free and bound TTP (red and black, respectively). 
Above each HSQC is a cartoon representation of TTP binding of the cognate RNA sequence. TTP 
undergoes an unfolding/ folded transition upon RNA binding.  
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Figure 1.8: NMR and computational studies have shown that in the absence of RNA the structure of 
the two zinc fingers of TIS11d are maintained, although their orientation changes. HSQC spectra of 
free and bound TIS11d (blue and magenta, respectively). Above each HSQC is a cartoon representation of 
TIS11d binding of the cognate RNA sequence.  
The structural rearrangement upon binding RNA is unique to the TZF of TTP. 
Structural studies of TIS11d bound to the single stranded RNA sequence 
5′UUAUUUAUU3′ (PDB code:1RGO) depicts two well folded zinc fingers, different 
than what we observed for TTP117. NMR and computational studies have shown that in 
the absence of RNA the structure of the two zinc fingers of TIS11d is maintained, 
although their orientation changes due to the flexible nature of the linker region (Figure 
1.8). The solved solution structure of the TIS11d/ RNA (U1-U2-A3-U4-U5-U6-A7-U8-
U9)  complex is held together mainly through backbone (not side chain) hydrogen bonds, 
van der Waals forces,  and base stacking interactions along Watson-Crick edges of each 
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nucleotide. Additionally, side chain residues E157, C174, and C212 form hydrogen 
bonds with RNA bases. The RNA lies along one face of the TZF, with ZF1 interacting 
with the 3' U6 and A7 nucleotides and ZF2 with the 5' U2 and A3 nucleotides. The linker 
region of TIS11d is also involved in hydrogen bonding with the bases of the RNA, 
resulting in a more rigid protein/RNA complex. Comparisons of the TIS11 family show 
that many of the aromatic associations (Y170, F176, Y208, and F218) with the RNA are 
conserved (Figure 1.6)118. Mutations of these residues in TTP to non-aromatic amino 
acids abrogates RNA-binding. High sequence similarity of residues at the protein-RNA 
interface and the zinc coordinating residues for both TTP and TIS11d suggests that the 
TZFs may present similar binding conformations to the 5′UUAUUUAUU3′ RNA. The 
residues that differ at these positions (K169 in the first finger of TIS11d is an arginine in 
TTP, and R198 is a histidine in TTP) are basic residues in both proteins and therefore 
should be able to make similar contacts with the RNA.  The positively charged amino 
acids along the protein/RNA interface neutralize the negatively charged phosphate 
backbone of the RNA allowing the binding of the TZFs to the single stranded RNA.  
TTP family members are the main facilitators of post transcriptional mRNA 
decay. Although all of the family members have the same type of CCCH tandem zinc 
finger RNA binding domain, the structure of this domain differs among family members. 
We hypothesize that the structure of these proteins dictates its binding activity in vitro 
and in vivo.  RNA recognition and binding by the TTP family is crucial as several human 
diseases, such as acute inflammatory disease and cancer are linked to post-transcriptional 
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dysfunction of these RBPs, we want to investigate how the TTP family members 
discriminate their mRNA targets. 
Scope of thesis project 
Tristetraprolin (TTP) is a prototype of the CCCH-type zinc finger proteins. 
Binding of TTP to AU-rich elements in the 3 ̍ UTR of many mRNA transcripts promotes 
deadenylation and consequent degradation of transcripts. This process provides an 
important mechanism for reducing the mRNA synthesis of key cytokines and growth 
factors associated with chronic inflammation and cancer. The TTP protein family in 
humans includes two other proteins, TIS11b and TIS11d. The TIS11b and TIS11d RNA 
binding domain (RBD) that consists of two CCCH zinc fingers (ZFs) shares a high 
degree of sequence identity to TTP and have TTP-like activity, yet neither TIS11b nor 
TIS11d can replace TTP function in TTP knockout mice. Additionally, TTP, TIS11b, and 
TIS11b have unique cell‐ and tissue specific expression, suggesting that they regulate 
different mRNA targets. Therefore, examining how the primary sequences of individual 
TTP family members influence cellular targets is essential for understanding their role in 
human physiology.   
Biophysical characterization of the TTP family members, TIS11b and TIS11d 
shows that both ZFs are folded in the absence of RNA in TIS11d and TIS11b. In TTP, 
however, only ZF1 adopts a stable fold. Through this work, we have identified the origin 
of disorder/order for TTP/TIS11d, respectively. We constructed chimeric proteins of the 
TZF domains of TTP and TIS11d and characterized their structure and RNA-binding 
activity. We found that three residues located at the C-terminal end of the -helix in ZF2 
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determine the structure of TZF domain.  Additionally, we observed that the mRNA 
destabilizing activity of TTP was increased when the partially disordered TZF domain of 
TTP was replaced with the fully structured domain of TIS11d. These results show that 
the degree of structure of the TZF domain affects the function of the protein in the cell 
and indicates that the protein can modulate its activity through its structure.  
This data was further supported through experiments on missense mutations 
localized in the RBD of TIS11d (P190L and D219E) that have been associated with acute 
myeloid leukemia and acute lymphoblastic leukemia, respectively. We observed that both 
mutations affect the structure and dynamics of the RBD of TIS11d. This result suggest 
how these mutations play a role in disease pathogenesis. Taken together, these results 
highlight how small variations in amino acid composition contribute to protein function 
both in vivo and in vitro.   
In Chapter II, we demonstrate how the structural differences in TTP and TIS11ds 
RBDs affect their RNA binding activity using fluorescence polarization (FP) to measure 
RNA binding and NMR to observe to characterize structural differences. Together, these 
data suggest that the structure and flexibility of the TTP family of proteins affects the 
selection of mRNA targets.   
In Chapter III, we evaluate the effects of mutations on the conserved six residue 
motif, the R(K)YKTXL sequence, preceding each zinc finger. Mutation of residue X in 
MEX5, from arginine or lysine to glutamic acid, results in increased RNA specificity of 
the TZF; for this reason this residue was identified as the discriminator residue. In this 
chapter we test whether or not the fifth residue is sufficient to act as a determinant of 
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RNA binding specificity in the TTP family. In TTP and TIS11d this is not the case, 
mutation of glutamic acid to arginine in ZF1 decreases the affinity of the protein for 
RNA, without making it more promiscuous. Mutation of glutamine to lysine in ZF2 does 
not affect the RNA binding affinity or specificity of TTP or TIS11d.  
Chapter IV, focuses on understanding the origin and biological significance of the 
structural differences between TTP and TIS11d. We identified three residues located in 
the -helix of TTP required for the folding of ZF2 in the absence of RNA. Despite their 
different folding propensities, TTP, TIS11d, and chimeras bound to RNA with similar 
affinity. In contrast, the mRNA destabilizing activity of TTP was increased when the 
partially disordered RBD of TTP was replaced with the fully structured RBD of TIS11d. 
These results indicate that differences in the folded state of the RBD, while not affecting 
the in vitro RNA-binding affinity, have a large effect on the biological activity of the 
proteins in the cell.  
In Chapter V, we investigate two missense mutations localized in the RBD of 
TIS11d (P190L and D219E) that have been associated with acute myeloid leukemia and 
acute lymphoblastic leukemia, respectively.  We observed that both mutations affect the 
structural flexibility of the RBD of TIS11d, yet the mutant variants bind similarly to the 
cognate RNA sequence. Confocal images taken for HEK293 cells of GFP tagged TIS11d 
show disperse cytoplasmic expression while the P190L and D219E mutants display 
puncta within the cytoplasm. This result suggests that the structure of the RBD of TIS11d 
affects its subcellular localization, which may explain its role in disease pathogenesis.  
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 The final chapter details how NMR and other biophysical techniques can be used 
to identify mutations in the TTP family that cause abnormalities in folding and RNA 
binding properties that result in TTP’s dysfunction leading to inflammatory disorder and 
cancer. Understanding the source of the TTP family dysfunction can aid in the 
development of potential therapeutics for disease.   
 
 
 
  
 
 
 27 
Chapter II: Characterizing the differential  
RNA binding activity of the human TTP family 
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Abstract 
The cell modifies gene expression in response to cues from its extracellular 
environment. Post-transcriptional regulation allows cells to control the production of 
various growth factors, inflammation mediators, and pro-oncogenic proteins at the RNA 
level. RNA-binding proteins (RBPs) ensure accurate post-transcriptional regulation by 
recognizing specific mRNA targets from a convoluted pool of cellular transcripts through 
stable sequence and/or structural interactions. One such RBP, tristetraprolin (TTP), binds 
the 3′ UTR of transcripts containing adenine/uracil rich elements (AREs). Binding of 
TTP to these transcripts promotes their rapid degradation within the cell. TTP is a 
member of a small family of proteins, whose mammalian members include TIS11b and 
TIS11d, which have TTP-like activity. However, neither TIS11b nor TIS11d can 
reproduce TTP function in TTP knockout mice indicating that they are not functionally 
equivalent. Our lab has shown that the RNA binding domain (RBD) of TIS11d and 
TIS11b are well folded in the absence of RNA. However, the RBD of TTP is only 
partially folded in its RNA-free state. Here we show that stable coordination of the 
adenine in TTP ZF1 promotes the folding transition of ZF2 in TTP to bind to RNA 
following an induced-fit model. In TIS11d where both ZF1 and ZF2 are folded in the 
absence of RNA, such a strong preference for RNA-binding is not observed. Therefore, 
the different structure and stability observed for the RBD domains of TTP and TIS11d 
affect how these proteins bind RNA sequences. These results highlight how proteins in 
the same family can recognize and regulate different transcripts in the cell. 
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Introduction  
The eukaryotic cell needs to modify the expression levels of many proteins in 
response to cues from the extracellular environment. One such mechanism for fine-tuning 
gene expression is through post-transcriptional regulation. By definition post-
transcriptional regulation control begins once the RNA polymerase begins RNA synthesis 
in the nucleus and continues until translation of the gene in the cytoplasm. During the 
process of mRNA biogenesis in the nucleus a number of factors begin to associate with 
the mRNA, including RBPs. Many RBPs associate with their target mRNA, and this 
complex is exported out of the nucleus into the cytoplasm where it alters the localization, 
translation and/or degradation of the mRNA.  Despite much previous effort, we still lack 
a thorough understanding of how many RBPs recognize and regulate their target mRNAs 
to control their cellular fate119.  
Tristetraprolin (TTP) is one post-transcriptional regulator that binds specifically 
to AU rich sequence elements (ARE) in the 3′–untranslated region (3′UTR)120 of many 
mRNAs encoding essential inflammatory mediators, including TNFα121, fibronectin122, 
interleukin-1α/ β122, and granulocyte-macrophage colony stimulating factor (GM-CSF)75. 
Recent computational analysis estimates that 8% of human transcripts contain AREs45. In 
1986, Cerami et al. determined that these common ARE sequences confer mRNA 
instability41.  TTP is one of the post transcriptional regulators responsible for governing 
the lifetime of these ARE containing mRNAs, inhibiting the expression of many essential 
cytokine and growth factor proteins by recruiting degradation machinery to their bound 
mRNAs. 
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Although the seminal member of this protein family (TTP) is well characterized, 
less is known about the other family members, TIS11d and TIS11b. These two family 
members were identified through increased expression after exposure to the tumor 
promoter, tetradecanoyl phorbol acetate (TPA), coining their name TPA Inducible 
Sequence 11 (TIS11) proteins123. The family is defined by a conserved RBD that is a 
CCCH tandem zinc finger. In this RBD these proteins share high sequence identity; 
TIS11b and TIS11d are approximately 70% identical to TTP, and 91% identical to each 
other. Outside of the RBD the family members share little sequence similarity (Figure 
2.1). The N- and C-terminal domains (NTD/CTD) of these proteins are necessary to 
ensure proper recruitment of the enzymes in the mRNA degradation pathway124. TTP 
activity is modulated spatially and temporally through protein-protein interactions at the 
NTD and CTD. Phosphorylation of these domains decreases TTP RNA binding125. 
Further TTP is a nucleocytoplasmic shuttling protein containing an N-terminal 
LxxxLxxLxL sequence that serves as a nuclear export signal (NES)68. Software to predict 
secondary structure from primary sequence suggests that the NTD and CTD contain 
minimal stable structural elements118. Regions lacking stable structures are difficult to 
study in vitro and so we focused on the conserved RBD of TTP and TIS11d to determine 
how each protein binds distinct mRNAs, targeting them for degradation.  
 
 
 31 
 
 
 
 
 
Despite being members of the same family and containing highly homologous 
RBDs, TTP and TIS11b/d are not functionally redundant. Genetic studies revealed 
further functional differences among TTP/TIS11 family members. Although TIS11b and 
TIS11d have TTP-like activity neither TIS11b nor TIS11d replaces TTP function in TTP 
Figure 2.1: The TTP family of proteins. Schematic representation of the human TTP family 
members, TTP, TIS11b, and TIS11d. The N-terminal domain (NTD) and C-terminal domain (CTD) 
are colored in gray and the RNA binding domain (RBD) is in purple. The percent homology of each 
domain to TTP and its nucleotide length is denoted below each domain. The TTP family share 
homology at their RBD, a tandem zinc finger connected by an 18 amino acid linker. The two zinc 
finger motifs, ZF1 and ZF2, have a characteristic CX8CX5CX3H zinc coordination (highlighted in 
red). Conserved R(K)YKTEL sequences preceding each finger are highlighted in blue. Residues 
directly involved in hydrogen bonds with RNA are highlighted are indicated with asterisks (*), 
those that stack with RNA bases are denoted with a green pound (#) sign.  
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knockout mice107. TTP 
knockout (KO) mice 
develop systemic 
inflammatory syndrome; 
cachexia, dermatitis, patchy 
alopecia, erosive arthritis, 
conjunctivitis, myeloid 
hyperplasia, and 
extramedullary 
hematopoiesis126. In contrast, 
TIS11b KO mice are embryonic lethal by day 11 due to vascular abnormalities and heart 
defects. TIS11d KO mice survive for approximately two weeks after birth, but then die of 
intestinal hemorrhage, pancytopenia, and reduced numbers of definitive multilineage and 
lineage-committed hematopoietic progenitors111. The differing mRNA expression 
patterns of TTP112 are expressed mainly in cervical tissue, and TIS11b/d, which are 
expressed in the pancreas and thymus, as well as differences in transcriptional regulation 
strongly suggest that the TTP family of proteins regulate different mRNA targets in the 
cell.   
The structure of the RBD of TIS11d in complex with single stranded RNA 
sequence 5′U1-U2-A3-U4-U5-U6-A7-U8-U9-3′was solved using nuclear magnetic 
resonance (NMR) spectroscopy (PDB code:1RGO)127.  The structure depicts two well 
folded zinc fingers. The TIS11d/RNA complex binds to RNA mainly though protein 
Figure 4.2: Structure of the TIS11d in complex with RNA. NMR 
structure of TIS11d depicts its antiparallel binding to its 
5′UUAUUUAUU3′ RNA substrate. ZF1 binds to the 3′ UAUU half 
site (blue), while ZF2 binds to the 5′ UAUU half site (red).  
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backbone hydrogen bonds and base stacking interactions along Watson-Crick edges of 
each nucleotide, with zinc finger 1 (ZF1) interacting with the 3′ U6-A7-U8-U9 halfsite 
and zinc finger 2 (ZF2) interacts with the 5′ U2-A3-U4-U5 halfsite (Figure 2.2). The 
linker region of TIS11d forms an extensive hydrogen bond network with the bases of the 
RNA, resulting in a rigid protein/RNA complex.  
The residues interacting with RNA are well conserved between TIS11d and TTP. 
The sequence differences are minimal at these positions; K169 and R198 of TIS11d 
correspond to R119 and H148 in TTP. These residues should maintain similar 
electrostatic contacts with the RNA. Mutations of many of these conserved residues 
affect TTP family RNA binding. For example, mutations to either the aromatic residues 
Y170 (Y120), F176 (F126), Y208 (Y158), and F218 (F168) in TIS11d (or their 
corresponding TTP residues) critical for forming base stacking interactions with the RNA 
and/or the zinc coordinating residues C159 (C109), C168 (C118), C174 (C124), and 
H178 (H128) in ZF1 and C197 (C147), C206 (C156), C212 (C162) and H216 (H166) 
result in complete abrogation of RNA binding118. Other important interactions in the TTP 
family RBD are with the conserved KTEL sequence preceding each finger (Figure 2.1 
blue). Mutations of this motif in TTP C.elegans family member MEX5 have been shown 
to confer specificity to the 5′UUUUAUUUAUUUU3′ sequence as adenine coordination 
is accomplished through hydrogen bonds of E157, L158, and R160 in ZF1, while E195, 
L196, and R198 bind with the adenine in ZF2 of the KTEL motif128,129.  
NMR and computational studies of TIS11d show that in the absence of RNA the 
structure of the two zinc fingers are maintain, although their orientation relative to one 
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another changes due to the flexible nature of the linker. Despite their high sequence 
identity (Figure 2.3a), the structure of the RBD differs between TTP/TIS11d in the 
ligand-free state127,128. Biophysical studies of the TTP TZF domain reveal that it is 
partially unstructured in the free state and undergoes folding only upon binding RNA 
(Figure 2.3b)130,131. We hypothesize that difference in TTP and TIS11d ligand-free 
structures affect their selectivity for mRNA targets in vitro.   
Previous work from our lab and others has used two dimensional NMR 
spectroscopy to observe changes in TTP and TIS11d RBDs upon binding their 
5′UUAUUUAUU3′ targets using an experiment referred to as 15N-1H heteronuclear 
single quantum coherence (HSQC) spectroscopy127,130,131. This two-dimensional NMR 
characterization provides us with an understanding of substrate binding at the atomistic 
level, not offered by other spectroscopic techniques. Since chemical shift is a measure of 
changes in local environment, we use it to map substrate binding onto each RNA binding 
domain, as binding RNA influences the distribution of electrons around the nucleus. 
Chemical shift differences in TTP upon RNA binding, ∆δ = [(10H)2 + N2]1/2, is 
plotted as a function of the residue number. H and N are the chemical shift changes 
observed for the 1H and 15N resonances in ppm, respectively. It is important to note that 
we cannot deconvolve whether the observed changes in chemical shifts are due to a 
conformational change of the protein or direct RNA contacts. However it does provide 
insights regarding what residues are undergoing changes in their local environment as a 
consequence of RNA-binding.  
 
 
 
 35 
Figure 2.3: The RBD of TTP and TIS11d are highly homologous, bind to cognate RNA similarly, yet 
differ in their RNA free states. A) A sequence alignment of the TZF of TTP and TIS11d. The TZF 
consists of two CCCH zinc fingers (ZF1 and ZF2 represented in boxes) and an 18 amino acid linker. The 
conserved R(K)YTEL motif is underlined. Residues that differ between the two proteins are shown in red. 
Residues directly involved in RNA binding in the NMR solution structure (PDB file 1RGO) are indicated 
with asterisks; black = hydrogen bonds, green = base stacking interactions. B) HSQC spectra of free and 
bound TTP (red and black respectively) and free and bound TIS11d (blue and magenta respectively). 
Proteins are bound to their cognate RNA (5´UUUUAUUUAUUUU3´) sequence. Above each HSQC is a 
cartoon representation of TTP and TIS11d binding of the cognate RNA sequence. TTP undergoes an 
unfolding/ folded transition, while TIS11d reorganizes its structure. C) Chemical shifts difference (Δσ) 
plots for (Left, red) TTP free (TTPF) to TTP bound to 5´UUUUAUUUAUUUU3´ (TTPB). In this panel we 
can only calculate differences for ZF1 and part of the linker since peaks are missing in the HSQC spectrum 
for ZF2 due to intermediate exchange line broadening; (Middle, blue) TIS11d free (TIS11dF) to TIS11d 
bound to 5´UUUUAUUUAUUUU3´ (TIS11dB); (Right, black) TIS11d RNA bound (TIS11dB) and TTP 
RNA bound spectra (TTPB). 
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15N-1H HSQC experiments were collected for TTP and TIS11d in the presence 
and absence of their target 5′UUUUAUUUAUUUU3′RNA sequence and chemical shift 
differences were calculated for ZF1 of TTP and TIS11d. Chemical shift difference plots 
for ZF1 RNA binding were similar, suggesting that TTP and TIS11d ZF bind their target 
mRNA in a similar manner (Figure 2.3C, top and middle). Additionally, we calculated 
the chemical shift variation of the 5′UUUUAUUUAUUUU3′ bound form of TTP and 
TIS11d (Figure 2.3C, bottom) and found that their chemical shift differences are 
minimal. Secondary structure prediction software using these chemical shifts determined 
that their protein structures are similar with the exception of the helix in the second finger 
where TTP forms one helical turn and TIS11d forms an extra turn. We therefore 
hypothesized that different structures of TTP and TIS11d unliganded states influence 
their RNA binding specificity for the UAUU half site at each finger.  
 In this study, we use fluorescence polarization (FP) coupled with NMR to 
investigate the mechanism of RNA recognition by TTP and TIS11d. Together, these data 
suggest that the structure and flexibility of the TTP family of proteins has a large effect 
on RNA recognition and the selection of mRNA targets.   
Results and Discussion 
The site specific interaction of TTP and TIS11d to variants of ARE13 
To understand TTP and TIS11d binding determinants, the binding of TTP and 
TIS11d were measured and compared to a series of fluorescently labeled ARE13 
(5′FAM-UUUUAUUUAUUU3′) RNA mutations that substitute the two adenosines to 
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uracils individually and together (Table 2.1 and 2.2). Red indicates the position mutated 
in the RNA sequence relative to the high affinity ARE13 sequence. 
Table 2.1: Equilibrium binding of TTP TZF to RNA substrates 
RNA Sequence 5′ to 3′ 
Kd apparent 
(nM) 
∆G (kcal 
mol -1) 
ARE 
Preference 
ARE13 UUUUAUUUAUUUU 10.1 ± 0.7 -10.7 1 
5U13 UUUUUUUUAUUUU 56 ± 4 -9.7 6 
3U13 UUUUAUUUUUUUU 63 ± 3 -9.7 6 
U13 UUUUUUUUUUUUU 340 ± 30 -8.7 34 
14mer UUUUUUAUUUUUUU 56 ± 2 -9.7 6 
ARE7 UAUUUAU 128 ± 2 -9.2 13 
 
Table 2.2: Equilibrium binding of TIS11d TZF to RNA substrates 
RNA Sequence 5′ to 3′ 
Kd apparent 
(nM) 
∆G (kcal 
mol -1) 
ARE 
Preference 
ARE13 UUUUAUUUAUUUU 11 ± 2 -10.7 1 
5U13 UUUUUUUUAUUUU 35 ± 5 -10.0 3 
3U13 UUUUAUUUUUUUU 41 ± 9 -9.9 4 
U13 UUUUUUUUUUUUU 101 ± 1 -8.0 9 
14mer UUUUUUAUUUUUUU 32.2 ± 0.4 -10.0 3 
ARE7 UAUUUAU 121 ± 4 -9.3 11 
 
Through use of fluorescence polarization assays, we determined that TTP forms 
high affinity complexes with its preferred substrate (Kd app = 10.1 ± 0.7nM) while it 
bound to 5′-UUUUUUUUUUUUU-3′ (U13) sequence with a 34-fold weaker affinity (Kd 
app = 340 ± 30nM), consistent with published data132. TIS11d, in contrast, does not seem 
as selective as TTP; it binds to the ARE13 target with a similar affinity to TTP (Kd app = 
11± 2 nM), while it bound to U13 sequences with only a 9-fold weaker affinity (Kd app = 
101± 1nM).  
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Both RBDs bind with the highest affinity when ZF1 and ZF2 are coordinated by a 
UAUU halfsite, with TTP showing the greater specificity. Substitution at either adenine 
nucleotide results in decreased affinity to both TTP and TIS11d. Substituting the 5′ 
(5U13) or 3′ (3U13) adenine for a uridine yields a 3- to 4-fold reduction in affinity for 
TIS11d, respectively. TTP experiences a 6-fold loss in affinity for either of these RNA 
variants as compared to the ARE13 sequence. Although, uridine substituted RNA 
sequences bind to TTP and TIS11d with less affinity than the cognate 
5′UUUUAUUUAUUUU3′ sequence, they still bind with high affinity.  These data 
suggests that TTP and TIS11d bind to other RNA targets besides ARE13 with high 
affinity. 
Investigating the effect of mutations in the cognate RNA sequence on TIS11d 
binding 
The solution structure of the TIS11d/RNA complex shows that ZF1 of TIS11d 
interacts with the 3′ U6-A7-U8-U9 halfsite and ZF2 interacts with the 3′ U2-A3-U4-U5 
halfsite127. Therefore, TIS11d ZF1 binds the 3′ adenine (A7) and ZF2 binds the 5′ adenine 
(A3). We examined how the chemical shifts change upon binding to various RNA 
sequences- ARE13, U13, 5U13, and 3U13 (Table 2.1 and 2.2), to see if TIS11d 
recognizes these RNAs in a similar structural manner to its bound ARE13 sequence.  
 
 
 39 
 
 
 
 
 
Figure 2.4: Investigating the binding of cognate RNA variants on TIS11d binding by NMR. 
HSQC spectra of TIS11d bound to 5U13 - 5′UUUUUUUUAUUUU3′ (red) overlaid with either TIS11d 
in complex with its high affinity ARE13 - 5′UUUUAUUUAUUUU3′ (black) binding partner, or with 
its low affinity U13 – 5′ UUUUUUUUUUUUU3′ (blue) binding partner. Beneath each HSQC are their 
respective chemical shift perturbation plots, each with a schematic representation of the TZF motif of 
TIS11d.  
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Figure 2.5: Investigating the binding of cognate RNA variants on TIS11d binding by NMR. HSQCs 
of TIS11d bound to 3U13 - 5′UUUUAUUUUUUUU3′ (cyan) overlaid with either TIS11d in complex with 
ARE13 - 5′UUUUAUUUAUUUU3′ (black), or with the U13 – 5′ UUUUUUUUUUUUU3′ (blue) binding 
partner. Beneath each HSQC are their respective chemical shift perturbation plots, each with a schematic 
representation of the TZF motif of TIS11d. 
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As expected, TIS11d in complex with 5U13 shows larger chemical shift changes 
at ZF2 when compared to its binding of ARE13 (Figure 2.4), while chemical shift 
changes at ZF1 are larger when compared to U13 binding (Figure 2.4). TIS11d in 
complex with 3U13 show larger chemical shift changes at ZF2 when compared to its 
binding of ARE13 (Figure 2.5), while chemical shift changes at ZF1 are larger when 
compared to U13 binding (Figure 2.5). These results are consistent with TIS11d binding 
the 3′ half site with ZF1 and the 5′ half site with ZF2 regardless of the RNA sequences 
that were used in these experiments (Figure 2.2).   
Investigating the effect of mutations in the cognate RNA sequence to TTP binding 
In order to determine if TTP binds RNA with the same registry as observed with 
TIS11d, where ZF1 binds to the 3′ U6-A7-U8-U9 halfsite and ZF2 coordinates the 3′ U2-
A3-U4-U5 halfsite, we collected 15N-1H heteronuclear single quantum coherence 
(HSQC) spectra of TTP with the same sequences. Chemical shift difference maps were 
generated for the ZF1, linker, and ZF2 regions comparing binding to the ARE13 and U13 
sequences. As with TIS11d, TTP binding to 5U13  shows larger chemical shift changes at 
ZF2 when compared to ARE13 binding, and binding to 5U13 shows larger chemical shift 
changes in ZF1 compared to binding to U13 (Figure 2.6). However, TTP binding to 3U13 
is more complex --- in the 15N-1H HSQC spectrum we observe peak disappearances 
corresponding to several residues of the adenine recognition pocket. In ZF1 crosspeaks 
from C109, R110, T111, F112, E114, R119, and A122 are not observed, and E107, L108, 
and S113 crosspeaks are weak. In ZF2, K143, T144, E145, C147, and K149 are absent 
while K143 and L152 are weak and barely above the noise level. Peak intensity 
 
 
 42 
differences in the 15N-1H HSQC spectrum mapped to the adenine coordination sites of 
TTP TZF suggested degeneracy in TTP binding not observed with TIS11d (Figure 2.7). 
 
 
 
 
Figure 2.6: Investigating the binding of cognate RNA variants on TTP binding by NMR. HSQC 
spectra of TTP bound to 5U13 - 5′UUUUUUUUAUUUU3′ (red) overlaid with TTP in complex with 
its high affinity ARE13 - 5′UUUUAUUUAUUUU3′ (black) binding partner or its low affinity U13 – 
5′ UUUUUUUUUUUUU3′ (blue) binding partner. Beneath each HSQC is their respective chemical 
shift perturbation plots with a schematic representation of the TZF motif of TTP.  
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Figure 2.7: Peak disappearance associated with TTP binding to ARE13 3′U - 
5′UUUUAUUUUUUUU3′. Below, HSQC spectra demonstrate that binding of TTP 
5′UUUUAUUUUUUUU3′ (cyan) causes signal loss to the adenine binding pocket. Peak heights are 
restored upon binding TTP to a shorter RNA sequence, ARE3U8, 5′UAUUUUUU3′ (magenta), which 
restrains TTPs ability to slide to other RNA binding sites. Above, schematic of chemical exchange 
process associated with binding each RNA. Additionally, peaks that are lost upon TTP binding to 3U13 
RNA sequence are mapped onto the NMR structure in red (PDB file: 1RGO) using PyMOL.  Also 
displayed are zinc atoms (grey spheres), uracils (blue), and adenines (yellow) bound to TTP.   
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We hypothesized that the cross peaks of the adenine binding pocket disappeared 
because of a chemical exchange process that is intermediate in the NMR timescale that 
leads to extensive line broadening. This may be caused by TTP binding this RNA 
sequence with 2 different registers (Figure 2.7). In order to test this hypothesis, we used a 
shorter RNA sequence, ARE-3U8 (5′UAUUUUUU3′), which contains no RNA bases 
other than those shown to directly hydrogen bond with the published TIS11d structure. 
By constraining TTP ZF1 to bind to the UUUU half site and ZF2 to the UAUU half site, 
we increased the number of cross peaks observed in the 15N-1H HSQC that mapped to the 
adenine binding pocket (Figure 2.7). When we then mapped these chemical shifts onto 
ZF1, the linker, and ZF2, we see that TTP binding to ARE3U8 is similar to that of 
TIS11d binding to 3U13. Namely, we observed larger chemical shift changes for ZF2 
when compared to binding to ARE13 and larger chemical shift changes are observed for 
ZF1 when compared to binding to U13 (Figure 2.8). This result indicates that in TTP, its 
folded ZF1 has higher affinity for the UAUU half site than its unfolded ZF2.  
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Figure 2.8: Investigating the binding of cognate RNA variants on TTP binding by NMR. HSQC 
spectra of TTP bound to ARE-3U8 - 5′UAUUUUUU3′ (magenta) overlaid with TTP in complex with 
ARE13 - 5′UUUUAUUUAUUUU3′ (black) or U13 – 5′ UUUUUUUUUUUUU3′ (blue) binding 
partner. Beneath each HSQC are their respective chemical shift perturbation plots, each with a 
schematic representation of the TZF motif of TTP.  
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TTP ZF1 preference for the 6UAUU9 subsite  
Binding of TTP to 3U13 causes signal loss in residues of both adenosine binding 
pockets, and we predict this is a result of the TTP ZF1 higher affinity for the UAUU 
sequence. In order to test this, we performed NMR experiments where TZF binds to a 
longer RNA sequence, 14mer- 5′UUUUUUAUUUUUUU3′ (Figure 2.9), which can 
accommodate ZF1 binding to the UUUU or the UAUU subsite. 15N-1H HSQC spectrum 
of TIS11d bound to this longer RNA sequence shows that TIS11d binds to the 3U13 
(5′UUUUAUUUUUUUU3′) and 5U13 (5′UUUUUUUUAUUUU3′) as crosspeaks 
corresponding to both binding registers are present. Furthermore, the crosspeaks we 
observed corresponding to these two binding registers are of the same intensity, 
demonstrating that TIS11d binds to 5U13 and 3U13 equally (Figure 2.9).  These results 
emphasize that RBPs from the same family, such TTP and TIS11d, can recognize and 
bind different cellular mRNA transcripts despite sharing significant sequence identity.  
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For TTP in the absence of RNA, only ZF1 is stably folded. Only until TTP stably 
binds its RNA substrate will ZF2 fold. In these experiments we show that coordinating 
ZF1 of TTP to an adenine containing halfsite, UAUU, allow for a more stable interaction 
with the RNA for the folding of ZF2.  In the solution structure of TIS11d there is an extra 
hydrogen bond formed by E157 in the adenine binding pocket of ZF1 that formed with 
the RNA (Figure 2.10). This hydrogen bond seems is necessary for TTP high affinity 
RNA binding since FP data analysis determined that ZF1 of TTP has a slightly higher 
affinity for the adenine than ZF2 (Table 2.2). This data suggests a possible model of TTP 
RNA binding where ZF1 hydrogen bonds with adenine to create a stable protein-RNA 
Figure 2.9: HSQCs using longer variant ARE13 RNA show that TTP ZF1 favors the UAUU half 
site, whereas TIS11d has no preference.  (Left) HSQC overlay of TIS11d bound to 5′-
UUUUUUAUUUUUUU3′ (black), 5U13 - 5′UUUUUUUUAUUUU3′ (red), and 3U13 – 5′ 
UUUUAUUUUUUUU3′ (blue). (Right) HSQC TTP bound to 5′-UUUUUUAUUUUUUU3′ (black) 
overlaid with 5U13 -5′UUUUUUUUAUUUU3′ (red). Atop each HSQC is a schematic representation 
of ZF1 and ZF2 RNA binding. TIS11d binds to this RNA sequence with 2 registries equally, whereas 
TTP binds in one registry where its ZF1 binds to the UAUU half site displaying TTP preference for the 
UAUU half sites. 
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complex for the folding of ZF2. Although we conclude an induced fit model of RNA 
binding, this does not preclude a small percentage of TTP that folds fully in its RNA free 
form and then binds RNA, similar to what we observe for TIS11d.  In TIS11d both ZF1 
and ZF2 are folded in the absence of RNA and therefore the additional hydrogen bond 
associated with adenine coordination is not necessary for it to form a stable protein-RNA 
interaction. Altogether, this data supports that the different structure and stability 
observed for RBD TIS11d and TTP affect how they bind their RNA targets in vitro.      
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Figure 2.10: Adenine binding pocket. A) A surface image of TIS11d (gray) in complex with ARE9- 
5׳UUAUUUAUU3׳ (yellow) (PDB access code: 1RGO).  The red box highlights TIS11d ZF1 adenine 
recognition pocket. B) Close up view of the adenine binding pocket of TIS11d ZF1. The adenosine base 
is in yellow. E157 is represented in green. E157 side chain carboxyl forms a hydrogen bond (red) with 
the exocyclic amine of the adenosine base. Backbone carboxyl of L158, L196 and backbone amide of 
R160, R198 also form hydrogen bonds (black) with the adenosine.  
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Figure 2.11: Binding of the UAUU half-site to the N-terminal zinc finger is not 
sufficient to promote complete folding of the TZF domain. Top: HSQC of TTP bound 
to ARE 5′UAUUAUU3′ (green) overlaid with ARE13 bound TTP (black). Middle: 
HSQC of TTP bound to 5′UAUUUAU3′ (purple) overlaid with ARE13 bound TTP (left, 
black) and the unliganded form of TTP (right, red). Bottom: HSQC of TTP bound to 
5′UUAUUUU3′ (cyan) overlaid with ARE13 bound TTP (left, black) and the unliganded 
form of TTP (right, red). Sandwiched between 5′UAUUUAU3′ and 5′UUAUUUU3′ 
binding HSQCs are frames taken from with HSQCs of unliganded TTP (red) and HSQCs 
of TTP bound to 5′UUAUUUU3′ (cyan), ARE13 (black), and 5′UAUUUAU3′ (purple) 
of amino acids of the first finger to follow chemical shifts associated with RNA binding. 
Conclusion: Binding of the half site fails to promote complete TTP TZF folding. 
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Binding an RNA octamer completes folding of the TTP TZF domain   
NMR studies performed by our lab and others demonstrated that only ZF1 and the 
linker are clearly resolved in the 15N-1H HSQC spectrum of the ligand-free form of TTP. 
However, cross-peaks are observed upon binding to its cognate RNA sequence, ARE13-
5′UUUUAUUUAUUUU3.′ These cross peaks correspond to the residues of the linker 
and ZF2 that were absent in the initial RNA-free spectra. The 15N-1H HSQC spectrum of 
TTP bound to RNA does not change when the RNA sequence is shortened to eight 
nucleotides in length, 5′UAUUUAUU3,′ (ARE8)- RNAs of this length will not disrupt 
any hydrogen bonds associated with ZF1 and ZF2 RNA binding (Figure 2.11). In fact, 
the 15N-1H HSQC spectrum of TTP bound to ARE8 overlays with the longer ARE13 
sequence with exception of cross-peaks assigned to residues A122, S160, and H163 of 
the linker and ZF2 which do decrease in intensity (Figure 2.11). When we examined TTP 
bound to RNA heptamers, ARE7- 5′UAUUUAU3′, we found that many additional peaks 
lost intensity in the 15N-1H HSQC spectrum. In these experiments, peaks associated with 
ZF2 binding were found to have very low intensity, approaching the signal-to-noise-limit. 
However, the spectrum associated with ZF1 binding to ARE7 is similar to what we 
observe for ARE13 binding. Loss of ZF2 interactions with the high affinity UAUU 
halfsite may also explain why we calculate a dissociation constant for the bound TTP: 
ARE7 complex (Kd,app = 128 ± 2nM) that is an order of magnitude smaller than that 
calculated for TTP:ARE13 complex (Kd,app = 10.1 ± 0.7nM). Additionally, TTP and 
TIS11d do not bind another RNA variant, 5UUUUAUU3, which lacks the 5′ halfsite 
required for ZF2 binding. In fact, the 15N-1H HSQC spectrum taken of TTP binding to 
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this sequence closely mimics that of the 
ligand-free form of TTP. The binding 
affinity of TIS11d and TTP for 
5UUUUAUU3 was also found to be low 
in competition gel shift assays. Therefore, 
only the lower limit of the binding range 
could be determined where Ki (apparent) was 
found to be >20 M (Figure 2.12). Overall, 
this data indicates that binding to the 
5′UAUUUAU3′ RNA sequence is not 
sufficient to fully stabilize the structure of 
ZF2.   
 
 
Figure 2.12: RNA competition of TTP and 
TIS11d bound to fluorescence labeled ARE13 with 
unlabeled 5′UUAUUUU3′. The fraction of TIS11d 
(top, blue) and TTP (bottom, red) bound to 
fluorescently labeled ARE13 (bound RNA = top 
band) is competed off with increasing concentrations 
of unlabeled 5′UUAUUUU3′ (free RNA = bottom 
band) with maximum concentration 20 µM. The 
unlabeled 5′UUAUUUU3′ RNA was unable to 
completely compete off the fluorescently labeled 
ARE13. Therefore we assume that the Ki, app > 20 
µM.  
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Conclusions 
In this study we used a combination of NMR and FP to gain a more complete 
understanding of how two proteins of the same family, TTP and TIS11d, bind to RNA 
sequences differently in vitro. Contrary to the intuitive expectation that increase in the 
flexibility of a protein leads to promiscuity in binding behaviors133-139, we found that the 
partially folded TTP TZF is more selective for binding the UAUU half site at ZF1 than its 
fully folded counterpart TIS11d. As discussed above, TIS11d binds 3U13 
(5′UUUUAUUUUUUUU3′) and 5U13 (5′UUUUUUUUAUUUU3′) sequences equally 
well. Meanwhile, we observed that TTP RNA binding being coupled to folding of a 
portion of its RBD increases its selectivity for the 5U13 sequence. Our results highlight 
that the TTP binding to an adenylate residue with ZF1 creates a stable scaffold upon 
which ZF2 can fold onto the remainder of the RNA through an induced fit mechanism. 
These results strongly indicate that TTP and TIS11d might have different mRNA targets 
in the cell and that this could account for the inability of TIS11d to rescue TTP knockout 
mice140.  
The high affinity binding of TIS11d and TTP to ARE13, 5U13, 3U13, and U13 in 
vitro suggests that these RNAs may also be in vivo targets. Experiments investigating 
TTP associated mRNA targets in HEK cells using Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation (PAR-Clip) identified TTPs interaction 
with 1,313 ARE rich sequences, many of which were interrupted by uridylated 
stretches141. These experiments, when considered in conjunction with our findings above, 
suggest that TTP may be able to bind to more RNA targets in vivo than just TTP’s 
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reported 5′UUAUUUAUU3′ target sequence. Furthermore, our research highlights the 
need for the identification of TIS11d biological targets, potentially through a more 
stringent search like PAR-Clip as our data shows that TIS11d and TTP have different 
affinities for the same sequences in vitro. More studies are needed to determine if they 
have distinct or overlapping targets in vivo.  
In the cell, the stability of the ARE containing 3′ UTR is governed through a host 
of post-transcriptional regulators to either promote or inhibit the ARE degradation 
machinery142. For example, human antigen R (HuR) is an ARE regulatory protein that 
enhances RNA stability by binding to U and CU-rich sequences while TTP binds to ARE 
to decrease mRNA stability143. Given their antagonistic behavior, much work has been 
done to investigate competition of these proteins for ARE 3 ̍UTRs. The current model 
posits that in response to cellular stress HuR binds to stabilize transcripts and promote 
their translation while TTP is being synthesized and phosphorylated by MAP kinase-
activated protein kinase 2 (MK2). Phosphorylation of TTP results in its interaction with 
the chaperone 14-3-3 dimer complex sequestering it away from RNA. Dephosphorylation 
of TTP by protein phosphatase 2A (PP2A), allows for TTP association with ARE 
containing RNA, displacing HuR and leading to mRNA degradation144. In this study we 
demonstrated that TTP binds to HuR binding sites (uridine stretches - U13 Table 1) with 
only a moderate affinity (340 ± 30 nM) while TIS11d binds the same sequence with a 
higher affinity (101 ± 1 nM), suggesting that TIS11d may be able to compete for 
uridinylated stretches more effectively than TTP and result in increased turnover of 
mRNA transcripts in cells. Indeed, previous research in our lab has determined that 
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replacing the TTP RBD with those of TIS11d leads to increased turnover of a reporter 
transcript containing the ARE 3′UTR. Differences in the ability of TTP and TIS11d to 
compete for mRNA targets provide an alternative explanation for the different 
phenotypes in TTP and TIS11d knockout mice.  
One interesting finding from this work was that mutations in ZF2 of TTP that 
have a significant impact on TTP′s protein folding actually have little effect on the total 
free energy of RNA binding for the canonical 5′UUAUUUAUU3′ sequence. It is possible 
that TTP RNA binding is an enthalpically favorable process due to the overall charge of 
the protein (TIS11d: +3, TTP: +8), compensating for the entropic penalty associated with 
RNA binding that is a result of the increased flexibility of TTP relative to TIS11d. 
Performing RNA binding titrations at different temperatures can be used to determine the 
enthalpic and entropic contributions to RNA binding through global analysis using 
Gibbs-Helmhotz relationship as done in previous work performed in our lab to 
characterize RNA binding of truncation mutations in TIS11d RBD that increase its 
protein dynamics.   
 Understanding the physical forces that drive TTP and TIS11d discrimination for 
their mRNA targets is critical for understanding how they regulate RNA turnover in the 
cell. Many other factors bind TTP affecting its activation/inactivation, localization, and 
mRNA degradation activity.  Whether RNA induced folding is involved in many of TTPs 
biological functions is still a mystery and will be an exciting area of research in the 
future.  
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Materials and Methods 
Sample preparation 
 The sequence encoding amino acids 100-170 (150-220), which includes the TZF 
domain of TTP (TIS11d), was expressed using pet21a expression vector. TTP and 
TIS11d were expressed in E. coli strain BL21-Codonplus (DE3) (Stratagene). Isotopic 
labeling with 15N was performed by growing the cells in M9 enriched with 1 g of 
15NH4Cl per liter.  13C labeling is performed by growing cells in 13C-glucose. The cells 
were grown at 37° C to an OD600 of 0.8 and then induced for 4 hours with 1 mM 
Isopropyl β-D-1 thiogalactopyranoside (IPTG) and 0.1 mM ZnSO4 at the same 
temperature. Harvested cells were passed through a cell disrupter in 50 mL lysis buffer 
containing 50 mM Tris HCl, pH 8.0, 50 mM NaCl, 2 mM dithiothreitol (DTT) and 1 
EDTA free Complete protease inhibitor tablet (Roche).  Lysates were centrifuged at 
19500 RPM for 1 hr at 4° C and passed through a 20 mL DEAE column pre-equilibrated 
with 50 mM Tris HCl, pH 8.0, 50 mM NaCl and 2 mM DTT. The flow through was 
dialyzed overnight in 25 mM sodium phosphate, pH 6.5, 50 mM NaCl and 2 mM DTT 
and passed through a HiTRAP SP 10mL column (GE healthcare Life Science) 
preequilibrated with  in 25 mM sodium phosphate, pH 6.5, 50 mM NaCl and 2 mM DTT. 
The peptides were eluted with a gradient of NaCl from 0-1 M; the peptides typically 
eluted at 0.2-0.6 M NaCl. Fractions with peptide were combined and concentrated to 2 
mL using a 3 KDa Centriprep (Millipore) and further purified using a 1.6 X 60 cm 
Superdex-75 size exclusion column (Amersham Biosciences) equilibrated with 50 mM 
Tris HCL pH 7, 300 mM NaCl, 2 mM DTT. For NMR analysis fractions with TTP, 
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TIS11d or chimeras were buffer exchanged into 10 mM Tris pH 6.2, 20 mM KCl, 2 mM 
DTT, 0.1 mM ZnSO4.   
 
Measurements of RNA-binding affinity 
The RNA-binding activity of the samples was determined using fluorescent polarization 
with fluorescein 5′ end labeled RNA as previously described briefly by Pagano et al.  The 
affinities of TTP and TIS11d for variants of the cognate RNA sequence: 5′-
UUUUAUUUAUUUU-3′ (ARE13) were measured by direct titration of 3 nM labeled 
RNA with increasing concentrations of protein. Varying concentrations of the protein 
were incubated for 3 hours at room temperature with 3 nM fluorescently labeled RNA in 
a buffer solution containing 10 mM TRIS (pH 8), 100 μM Zn(OAc)2, 100 mM NaCl, 
0.01 mg tRNA, 0.01% (v/v) IGEPAL, and  2 mM TCEP. To detect the fluorescently 
labeled RNA, the gel was imaged using a Fuji FLA-5000 laser imager. The apparent 
dissociation constant Kd,app was determined by fitting to the quadratic equation 
𝑓 =
𝑚−𝑏
2𝑅
(𝐾𝑑 + 𝑃 + 𝑅 − √[𝐾𝑑 + 𝑃 + 𝑅]2 − 4𝑅𝑃) + 𝑏, 
where m and b are the maximum and base signals, Kd is the dissociation constant, and P 
and R are the concentrations of protein and labeled RNA in the sample, respectively. 
 
NMR spectroscopy  
Three dimensional triple resonance (1H-13C-15N) experiments, including HNCO, 
HN(CA)CO, HNCA, HN(CO)CA, HNCACB, and CBCA(CO)NH, have been collected 
at 14.1 T and 298 K to assign the backbone 1H, 13C, and 15N resonances of [U-13C, U-
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15N] TTP and TIS11d in 92% H2O/8% D2O buffer solution (10 mM Tris, 20 mM KCl, 2 
mM DTT, 0.1 mM ZnSO4 at pH 6.2). Additional 3D 15N edited 1H–1H NOESY and 
HMQC-NOESY-HSQC experiments were collected at 14.1 T and 298 K and used to aid 
in the backbone resonance assignment of each free and RNA bound RBD. All NMR 
triple-resonance and 15N-1H HSQC experiments were collected on a Varian Innova 
spectrometer operating at 600 MHz equipped with a triple-resonance cold probe. The 
temperature was calibrated using a sample of 100% methanol. Data processing was 
performed using NMRPipe 145 and Sparky software146. The chemical shift differences, Δ, 
were determined using Δ = (δH2 +  (δNγN/γH)2)1/2, where δH is the chemical shift difference 
of  1H, δN is the chemical shift difference of 15N and γN, γH are the gyromagnetic ratio of 
1H and 15N atoms. 
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Chapter III: Identifying deleterious mutations associated with 
conserved sequences in the TZF of the TTP family 
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Abstract 
The TTP family of proteins is required to accurately recognize mRNAs encoding 
inflammation mediators and oncogenic proteins, resulting in their precise turnover in the 
cell. Many of these protein-RNA interactions occur at a conserved 6 residue 
R(K)YKTEL sequence preceding each zinc finger (ZF) in the tandem zinc finger (TZF), 
including the coordination of the adenosines of its ARE13- UUUUAUUUAUUUU target 
RNA sequence. Missense mutations in the TIS11d ZF1 R(K)YKTEL motif are known to 
correlate with bladder, breast, liver and lung carcinomas. In the C.elegans RNA binding 
protein MEX-5, this motif is maintained except for a substitution of the glutamate at 
position five for an arginine in zinc finger 1 (ZF1) and a lysine in zinc finger 2 (ZF2) 
(Figure 3.1). Unlike the TTP family of proteins, MEX-5 is a promiscuous RNA binding 
protein that recognizes uridine-rich RNA sequences. However, in MEX-5 upon mutation 
of the R, K residues of the motifs to E as in TTP motif, MEX-5 gains TTP-like specificity 
and binds an adenine-uridine rich element (ARE) with higher affinity than a sequence of 
polyuridine. To explore the role of the primary sequence on the binding specificity of 
TIS11d and TTP, we mutated the glutamate of the R(K)YKTEL motifs in TIS11d and 
TTP to Arg/Lys in ZF1/ZF2, respectively, to mimic the sequence of MEX-5. We found 
that replacing the glutamate residue of the R(K)YKTEL motif with an arginine in the ZF1 
of TIS11d and TTP impairs RNA binding, likely due to conformational distortions of the 
adenine binding pocket of ZF1, more severely in TTP than in TIS11d. Additionally, we 
found that the arginine mutation at ZF1 in TTP decreased its mRNA turnover activity, 
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consistent with impaired RNA binding.  Mutation of the Glu to Lys in ZF2 does not 
affect the RNA-binding affinity nor the specificity of TTP and TIS11d. 
 
Introduction 
RNA binding proteins (RBPs) are the main facilitators of many biological 
processes, including post transcriptional regulation. Therefore, it is important to 
understand how these proteins recognize and bind to their RNA targets. RBPs bind to 
RNA using a variety of structural motifs called RNA binding domains (RBDs). Some of 
the most-abundant RBDs are RNA recognition motifs (RRMs)16,17, double stranded 
RNA-binding domain (dsRBD)18,19, K Homology (KH) domains20,21, and tandem zinc 
fingers (TZFs)22-24. One of the most selective RBDs is the CCCH TZF domain; a small 
domain, approximately 70 amino acids in length. The CCCH TZF contains minimal 
secondary structure elements and folds according to the coordination of three cystines 
and a histidine residue by a zinc ion147. Proper RNA recognition and binding by TZF 
proteins is crucial during development when transcription is typically repressed1-5 and 
during inflammatory responses6 when multiple genes are coordinated rapidly in response 
to external cues. Therefore, examining how the primary sequence of the TZF influences a 
protein′s cellular targets is essential for understanding their role in human physiology.   
In work done by Pagano et al. and our lab have shown that small changes in a 
conserved R(K)YKTXL sequence preceding each finger motif (Figure 3.1) are 
responsible for the specificity of targets seen across other CCCH TZF RBPs (Table 
3.1)148. Previous studies on the TZF protein from C. elegans MEX-5 suggested that 
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changes to the primary R(K)YKTR(K)L sequence result in different RNA binding 
specificities. Wild type MEX-5 binds to RNA with high affinity and low specificity, 
binding to RNA with stretches of six or more uridines within an eight nucleotide 
window148. The TTP family binds to the AU rich sequence elements (ARE), 
UUAUUUAUU, with high specificity149. Upon mutation of the MEX-5 binding motif 
R(K)YKTR(K)L to mimic the canonical TTP family binding sequence R(K)YKTEL, 
MEX-5 gains TTP-like specificity, binding AU rich elements with higher affinity than a 
sequence of polyuridine. This suggests that the basic residues provide the lower 
specificity observed in the MEX-5 binding site. Based on these studies of MEX-5 the 
fifth residue position has been coined the "discriminator residue148."  
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Figure 3.1: Sequence alignment of human and C. elegans CCCH tandem zinc fingers. Alignment 
of ZF1 (top) and ZF2 (bottom) of the human TTP family and C.elegans CCCH members. Top of each 
sequence alignment highlights residues directly involved in RNA binding in 1RGO solution NMR 
structure which are indicated with asterisks; black = hydrogen bonds, green = base stacking 
interactions. The three cysteines and histidine involved in zinc coordination are bolded in black. The 
conserved R(K)YKTXL sequence preceding the ZF is boxed in gray. Sequence differences of the 
R(K)YKTXL region are colored for positively charged (red), negatively chared (blue), and 
hydrophobic (orange) side chains. 
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Table 3.1: Differences in discriminator residues and their RNA recognition 
sequence 
CCCH protein ZF1 ZF2 
Recognition sequence  
*R=AorG, G=A,G,orT, N=any nucleotide 
TTP E E UUAUUUAUU127 
POS-1 A V UAUURDNNG150 
OMA-1 V K UA(A/U) repeat151 
MEX-5 R K U rich repeats148 
 
The RNA binding protein tristetraprolin (TTP), and its homologues TIS11b and 
TIS11d, are required for post-transcriptional repression of many different genes 
associated with inflammation and cancer initiation/progression in mammals152. TTP 
family members mediate post-transcriptional repression by specifically binding to ARE 
containing mRNA targets to promote their degradation153. The origin of mRNA binding 
specificity of the TTP family has not yet been determined. We hypothesize that the 
glutamate in the conserved R(K)YKTEL motif is critical for the RNA binding specificity 
of the TTP family.  
Studies in our lab and others have shown that the TTP family binds with the 
highest affinity to RNAs containing two UAUU half sites (Table 3.1). The NMR solution 
structure of TIS11d bound to ARE9 UUAUUUAUU depicts an adenine binding pocket 
residues involving residues of the conserved R(K)YKTEL sequence preceding each 
finger (Figure 3.1). The TIS11d/RNA complex is held together mainly though protein 
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backbone hydrogen bonds, with exception of the side chain residues E157, C174, and 
C212.  Previous work in our lab determined that hydrogen bonds with E157 (E107) in 
TIS11d (TTP) help to stabilize its interaction with RNA. These results suggest that 
residues in this motif are critical for the high affinity RNA binding and specificity 
observed in the TTP family. In support of this hypothesis, mutation of the third position 
of the motif (K105) in TTP is linked to bladder urothelial carcinomas, and mutation of 
the fifth motif position in TIS11d (E157) is observed in patients with bladder, breast, 
liver and lung carcinomas102. 
In order to determine if the ionic charge dictates RNA discrimination of TTP and 
MEX-5 R(K)YKTEL motif, we mutated the acidic glutamate residues in TTP and 
TIS11d to arginine in ZF1 and lysine in ZF2, similar to those residues found in MEX-5. 
The RNA binding activities of the mutant proteins, both the single and double mutant, 
were measured via fluorescence polarization using variant RNA sequences (Tables 3.2 
and 3.3). Additionally, we used nuclear magnetic resonance (NMR) spectroscopy to 
determine the structural differences that occur upon RNA binding. Finally, we performed 
an in vivo luciferase assay to study how changes in the R(K)YKTEL motif of TTP alters 
its activity in the cell.  We found that mutation of the R(K)YKTEL in ZF1 are 
detrimental to TIS11d and TTP RNA binding activity, but has a larger effect on TTP. 
Mutation of the Glu in ZF2 to Lys does not affect the RNA binding affinity of TTP and 
TIS11d.  
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Results and Discussion 
Changes in the conserved R(K)YTEL motif  results in decreased RNA binding 
affinity of TTP and TIS11d  
The solution structure of TIS11d/ARE9 (U1-U2-A3-U4-U5-U6-A7-U8-U9) 
complex determined that ZF1 of TIS11d interacts with the U6-A7-U8-U9 halfsite and 
ZF2 interacts with the U2-A3-U4-U5 halfsite. Therefore, TIS11d ZF1 binds the adenine 
located at the 3′ end and ZF2 binds the adenine located at the 5′ end of the RNA. We 
substituted uracil residues for adenines in the high affinity ARE13 
(UUUUAUUUAUUUU) to elucidate the putative role of the R(K)YKTEL sequence in 
determining the binding specificity of the TTP family. Using fluorescence polarization 
(FP) we measured RNA binding after substituting ZF1 glutamate residues for arginine 
(TTP E107R, TIS11d E157R) and ZF2 glutamate residues for lysine (TTP E145K, 
TIS11d E195K)  
In the tables below the halfsite bound by ZF2 is italicized and shown in bold face, 
while the halfsite bound by ZF1 is underlined. 
Table 3.2: Comparison of mutant TIS11d binding equilibrium FP measurements 
RNA WT 
TIS11d 
(ZF1)E157R (ZF2)E195K (ZF1)E157R/ 
(ZF2)E195K 
UUUUAUUUAUUUU 8 ± 0.4 nM 21 ± 2 nM 11 ± 1 nM 16 ± 1 nM 
UUUUUUUUAUUUU 45 ± 8 nM 102 ± 20 nM 50 ± 3 nM 103 ± 23 nM 
UUUUAUUUUUUUU 39 ± 6 nM 74 ± 4 nM 58 ± 5 nM 60 ± 4 nM 
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Table 3.3: Comparison of mutant TTP binding equilibrium FP measurements  
RNA WT TTP (ZF1)E107R (ZF2)E14
5K 
(ZF1)E107R/ 
(ZF2)E145K 
UUUUAUUUAUUUU 9 ± 0.5 nM 64 ± 6 nM 9 ± 1 nM 48 ± 3 nM 
UUUUUUUUAUUUU 62 ± 2 nM 527.5 ± 353 nM 34 ± 3 nM 223 ± 57 nM 
UUUUAUUUUUUUU 66 ± 2 nM 612 ± 92 nM 51 ± 4 nM 222 ± 21 nM 
 
We found that mutation of the glutamate of ZF2 R(K)YKTEL motif (TIS11d 
E195K, TTP E145K) had a limited effect on substrate binding. The TTP ZF2 E145K 
mutation increases the RNA binding affinity of ZF2 for not only the UAUU halfsite, but 
also the UUUU halfsite. Therefore, changing the electrostatics of ZF2 to make it more 
positive mildly enhances the affinity of TTP for negatively charged RNA.  Conversely, 
TTP ZF1 E107R mutation in the adenine binding pocket decreases the TZF affinity of 
TTP for all RNA substrates. To a smaller extent, this is also observed for the TIS11d 
E157R mutant of ZF1, which decreases the TZF affinity of TIS11d for all substrates by 
approximately half. We therefore sought to understand why mutations in ZF1, but not 
ZF2, lower the affinity of both TIS11d and TTP for all RNA substrates.  
 Structural analysis explains the loss of affinity observed when the ZF1 glutamate 
is mutated. The NMR solution structure of TIS11d shows that backbone hydrogen bonds 
from E157, L158, and R160 in ZF1 and E195 L196, and R198 in ZF2 coordination of the 
adenine. Of particular interest to our findings, the E157 side chain carboxyl in ZF1 forms 
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a hydrogen bond with the exocyclic amine of the adenosine base stabilizing the adenosine 
interaction with ZF1. This hydrogen bond is absent in ZF2 potentially explaining the lack 
of an effect on affinity observed with mutation of the Glu of ZF2 to Lys.  The homology 
model of the E157R/E195K mutation based on the TIS11d TZF structure suggests that 
substituting the glutamate in ZF1 with arginine results in a loss of base-specific hydrogen 
bonds, where the side chain carboxyl can no longer bind to the exocyclic amine of the 
adenosine base (Figure 3.2). Our studies of TTP indicate that RNA is necessary to 
promote the folding transition of ZF2, as predicted by the induced-fit model. Mutations 
that destabilize the interaction of the folded ZF1 with RNA, such as TTP E107R that 
disrupt the adenine binding pocket, have a strong negative effect on RNA binding since 
binding induces folding of ZF2. In TIS11d where both ZF1 and ZF2 are folded in the 
absence of RNA, such a strong deleterious effect on RNA-binding is not observed upon 
mutation of E157 to an arginine residue.  Therefore, the different structure and stability 
observed for the TZF domains of TTP and TIS11d affect how these proteins respond to 
mutations of residues critical for RNA binding.  
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Figure 3.2:  Adenine binding pocket of E157R/E195K mutation. A) A homology model of 
E157R/E195K (purple) bound to ARE9- 5׳UUAUUUAUU3׳(yellow) overlayed onto the surface structure 
of the solved TIS11d structure (gray) (PDB access code: 1RGO).  The red box highlights TIS11d ZF1 
adenine recognition pocket. B) Close up view of the adenine binding pocket of TIS11d ZF1. The 
adenosine base is in yellow. E157 is represented in gray. E157 side chain carboxyl forms a hydrogen bond 
(black) with the exocyclic amine of the adenosine base. When the glutamate (gray) is replaced with a 
bulky arginine residue (purple) in ZF1, this hydrogen bond is lost.   
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Replacing the glutamates in of the conserved R(K)YTEL sequence affects TTP 
HSQC 
 Previous studies of the human TTP TZF in our lab and others have found that ZF2 
undergoes a large conformational change upon RNA binding. In the RNA-free state, only 
ZF1and the first half of the linker of TTP are clearly resolved in the spectra. However, 
the missing peaks from the linker and ZF2 appear in the spectrum upon addition of RNA, 
indicating that these residues become more ordered upon RNA binding. This is also 
observed in the E145K mutant of TTP, thus mutation of the glutamate at ZF2 does not 
affect the ability of ZF2 to fold and bind RNA (Figure 3.4). The 15N-1H HSQC spectra of 
E107R mutant TTP and E107R/E145K double mutant are similar to that of TTP, 
indicating that the mutations do not affect the structure of the protein in solution (Figure 
3.3). Addition of RNA to ZF1 E107R mutant and E107R/E145K double mutant, 
however, causes precipitation of the proteins. The precipitation the E107R and 
E107R/E145K proteins observed upon addition of RNA in the NMR experiment suggests 
that the proteins are not stable in solution in the presence of RNA at the concentrations 
used in this experiments (50 µM). Although the protein concentration was much lower (2 
µM), we cannot exclude that there is some precipitation of these proteins in the FP RNA 
binding assay, explaining the low measured RNA binding affinity.  
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Figure 3.3: E107R, E145K, and E107R/E145K mutations have very little effect on TTP fold. 15N-1H 
HSQC overlays of TTP (red) and E107R/E145K (purple), E107R (cyan), and E145K (blue). Extra peaks in 
E145K, especially in the 8ppm region, can be due to the presence of a 19 amino acid, 
MHHHHHHGLEVLFQGPLGS, tag left on the protein to facilitate purification. 
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Figure 3.4: E145K mutation has minimal effect on TTP binding to ARE13. Top: 15N-1H HSQC spectra 
of TTP (red) bound to ARE13 - 5´UUUUAUUUAUUUU3´ (black). Above the HSQC is a cartoon 
representation of TTP binding to RNA. TTP undergoes an unfolding/ folding transition upon RNA binding. 
Bottom: HSQC spectrum of TTP E145K (blue) and TTPE145K: ARE13 (magenta) demonstrates the same 
unfolding/folding transition as that seen for TTP.   
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Examining the ability of the mutants to degrade TNF-α in HEK cells   
A luciferase reporter assay 
shows that targeted mutations 
affect TTP cellular function 
(Figure 3.5). HEK293 cells were 
co-transfected with a plasmid 
containing individual TTP mutants 
and a reporter gene encoding 
Renilla luciferase fused to the 
3′UTR of TNF-α, a known 
recognition site for the TTP 
family. In this assay, decreased 
Renilla luciferase expression is indicative of luciferase mRNA turnover in the cell, and 
therefore increased TTP activity. As expected the ZF2 mutation E145K, which does not 
affect the RNA binding affinity nor specificity of the protein, has similar luciferase 
activity to wild type TTP. A previously characterized mutant, C162S, which cannot bind 
RNA due to the loss of zinc coordination in ZF2, shows increased luciferase activity. 
E107R and dual E107R/E145K mutant forms of TTP display elevated luciferase activity 
on par with C162S. We therefore conclude that the ZF1 E107R mutation in TTP displays 
an increase in luciferase activity due to its inability to bind properly to ARE RNA. 
Therefore, consistent with our in vitro RNA binding data, changes in the conserved 
Figure 3.5: Measurements of the cellular activity of WT 
TTP and E107R/E145K mutations. The E107R mutation of 
TTP affects the mRNA destabilizing activity of TTP in 
HEK293 cells. The plot shows the relative luciferase activity 
measured for HEK293 cells incubated for 48 hours with empty 
pcDNA 3.1 plasmid, WT TTP, C162S, E107R, E145K, or 
E107R/E145K  mutations. 
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R(K)YKTEL sequence preceding ZF1 impair TNF-α turnover by TTP due to the 
decreased ability of the protein to bind the target RNA sequence.  
 
Changes in the R(K)YKTEL sequence preceding each zinc finger have a small effect 
on chemical shift perturbations of apo TIS11d  
In order to characterize the effect of E157R, E195K, and E157R/E195K 
mutations on TIS11d we used NMR spectroscopy. 15N-1H HSQC spectra collected for 
E157R, E195K, and E157R/E195K are similar to that of WT TIS11d, indicating that the 
mutations do not affect the overall structure of the protein (Figure 3.7a). The overall 
chemical shift perturbations (CSPs) observed between wild-type TIS11d and E157R, 
E195K, and E157R/E195K were small. As expected, CSPs for TIS11d ZF2 E195K are 
observed at or near the mutation site. In TIS11d ZF1 E157R mutation CSPs are not only 
observed for residues that are in close proximity to the mutation, either in space or 
primary sequence, but also in ZF2 (Figure 3.6). This observation suggests that this 
mutation affects the conformation of the flexible linker that allows a different 
arrangement of ZF1 and ZF2 in solution relative to the wild type protein. In addition to 
perturbing the adenine binding site, this mutation might also affect RNA-binding through 
its effect on the orientation of the ZFs in the free state.  
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Figure 3.6: Chemical Shift Perturbations (CSPs) of RNA free TIS11d, E157R, E195K, and 
E157R/E195K.  A) 15N-1H HSQC overlays of TIS11d (red) and E157R/E195K (purple), E157R (cyan), 
and E195K (blue). Below are Chemical Shift Perturbation (CSPs) plots of TIS11d minus each R(K)YKTEL 
mutation. B) CSPs of TIS11d minus E157R are mapped onto the solution structure of bound TIS11d 
(1RGO).  Zinc is shown as gray spheres. White indicates minimal chemical shift variations between 
TIS11d and E157R spectra, while red residues are those with higher chemical shift differences.  G179 has 
the highest chemical shift variation, since it is adjacent to the mutated site. However, chemical shift 
variations are mapped through the length of TIS11d TZF. 
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Changes in the R(K)YKTEL sequence preceding each zinc finger do not alter 
TIS11d binding registry 
 Chemical shift difference maps were calculated from 15N-1H HSQCs of WT and 
E157R/E195K TIS11d mutant RBDs between the free and ARE13-bound states (Figure 
3.7). Chemical shift difference of E157, E195K and E157R/E195K bound to RNA 
indicate that the mutations have little effects on cognate ARE13 (UUUUAUUUAUUUU) 
binding. Although present in the WT spectrum, in the 15N-1H HSQC spectrum of TIS11d 
ZF1 E157R mutation, cross-peaks for R160 and R198 are low in the noise and therefore 
are absent in the chemical shift analysis. Peaks for R160 and R198 are present in the 
ARE13 bound E157R/E195K dual mutant; however are also low in intensity. In the   
15N-1H HSQC spectrum taken for TIS11d ZF2 E195K mutation, these peaks are present 
with similar intensity to WT TIS11d. In the NMR structure of TIS11d, R160 and R198 
form hydrogen bonds when bound to the ARE sequence and consequently shift upfield in 
the bound 15N-1H HSQC spectrum (boxed in 15N-1H HSQC spectrum). Given the signal 
to noise ratio of these experiments, we cannot determine if the E157R mutation weakens 
the hydrogen bonds between R160 and R198 and the RNA. More work will be needed to 
determine if this is the case.  
 
Figure 3.7: Mutations of the highly conserved sequence have little effects on the overall conformation 
of ARE13 bound TIS11d. 15N-1H HSQC overlays of TIS11d (red) and E157R/E195K (purple), E157R 
(cyan), and E195K (blue) overlaid with their ARE13 bound 15N-1H HSQCs (gray). In the right hand corner 
of each spectra, with exception of E157R with peaks absent in its 15N-1H HSQC) there is an inset 
representing peaks R198 (left) and R160 (right). In the dual RK (E157R/E195K) mutation the R160 peak 
appears absent; however, this peak is in the noise. Below are Chemical Shift Perturbation (CSPs) plots of 
TIS11d minus TIS11d ARE13 bound spectra.  
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Previous work in our lab determined that TIS11d ZF1 binds the 3′ U6-A7-U8-U9 
half-site and ZF2 binds the 5′ -U2-A3-U4-U5 half-site of the ARE9 (U1-U2-A3-U4-U5-
U6-A7-U8-U9) RNA sequence. Here we investigate chemical shift differences associated 
with E157R and E195K bound to different RNA sequences to test if these mutants bind 
RNA with a similar 3′ to 5′ binding registry. In these experiments we compared chemical 
shifts associated with ARE13 (UUUUAUUUAUUUU) binding to uracil substitutions for 
one or both RNA adenosines. Relative to ARE binding to E157R/E195K TIS11d, binding 
of 5U13 (UUUUUUUUAUUUU) shows larger chemical shift changes at ZF2, whereas 
binding of 3U13 (UUUUAUUUUUUUU) shows larger chemical shift changes in ZF1 
(Figure 3.8). TIS11d binding to U13 (UUUUUUUUUUUUU) is associated with the 
combined chemical shift changes that we observe for 5U13 and 3U13, in that larger 
chemical shift changes are observed for both ZF1 and ZF2 relative to ARE13. These 
results are consistent with all the mutant proteins binding the four different RNA 
sequence using the same register of the WT protein, thus binding the 3′ half-site with ZF1 
and the 5′ halfsite with ZF2 regardless of uracil substitution. Therefore the mutations do 
not alter TIS11d RNA binding register.  
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Conclusions 
The TZF domain of the C. elegans protein MEX-5 binds RNA with high affinity 
and low specificity to uridine rich stretches. In contrast, the mammalian proteins TIS11d 
and TTP bind to 5′UUUUAUUUAUUUU′3 with high affinity and specificity. The 
relaxed binding specificity seen in MEX-5 is attributed to the Arg/Lys (R274/K318) in 
the fifth residue (X) of the highly conserved R(K)YKTXL motif preceding each zinc 
Figure 3.8: TIS11d, E157R, E195K recognition RNA with a 3′ to 5′ polarity regardless of 
uridine substitution of the UAUU subsite.  a) HSQCs of TIS11d bound to ARE13 5׳U - 
5׳UUUUUUUUAUUUU3׳ (red), ARE13 3׳U - 5׳UUUUAUUUUUUUU3 (cyan), and U13 – 5׳ 
UUUUUUUUUUUUU3׳ (blue) overlaid with TIS11d in complex with ARE13 – 
5׳UUUUAUUUAUUUU3׳(black). Beneath each HSQC are their respective chemical shift 
perturbation plots, each with a schematic representation of the TZF motif of TIS11d. b) HSQCs of 
E157R bound to each RNA sequence with its corresponding chemical shift perturbation plots below. 
c) E195K in complex with RNA variants overlaid with ARE13. CSP maps give similar profile as 
those seen for WT TIS11d.  
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finger in the CCCH TZF. In the mammalian proteins the fifth residue (X) is always a 
glutamate, whereas in C.elegans proteins, this position is less uniform. In this study we 
explored the effects on the RNA-binding activity of the equivalent mutations in TTP and 
TIS11d, E107R/E145K and E157R/E195K. We found that mutations of the R(K)YKTEL 
in the first finger are detrimental to both TIS11d and TTP UAUU binding activity. 
Mutating the glutamate in ZF1 to a bulky arginine residue resulted in a loss of RNA 
binding affinity. These results exemplify the challenges associated with defining the 
recognition code for all CCCH tandem zinc fingers since what is applicable for one 
CCCH family member may not be true for all CCCH members. As the field advances, 
and more structures are deposited for CCCH proteins in complex with their cognate RNA 
sequences, we can begin to understand how structure as well as primary sequence 
changes of more than one amino acid, influences RNA specificity for all of the CCCH 
family.  
 For TIS11d and TTP, the integrity of the conserved R(K)YKTEL eukaryotic 
sequence is essential for high affinity RNA binding. This sequence motif makes 
necessary interactions with RNA seen in the NMR structure of TIS11d in complex with 
high affinity UUAUUUAUU sequence. In this study we show that mutation of the 
glutamate residues at position 157 (107) to arginine severely impacts the ability of 
TIS11d (TTP) to bind RNA with high affinity. Mutation of E195 (E145) does not affect 
the RNA binding affinity of TIS11d (TTP). This is reflected in the cellular luciferase 
reporter assays which determine that E107R of ZF1 impairs TNF-α degradation by TTP. 
Homology modeling of E157R and E195K mutations onto the published TIS11d 
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structure suggests that TTP E107R and TIS11d E157R mutations may cause changes to 
the adenine binding pocket that preclude RNA binding at ZF1 due to the increase in size 
of the side chain moiety.  This finding contradicts our original hypothesis, which was that 
the positively charged residues would form more favorable interactions with the 
negatively charged RNA backbone to allow more promiscuous binding. Furthermore, this 
finding suggests that not only electrostatic, but also steric interactions between the RNA 
and protein play a large role in mRNA specificity.  
Consistent with the biophysical and biochemical data, mutation of the third 
position of the R(K)YKTEL motif (K105) in TTP is linked to bladder urothelial 
carcinomas, and mutation of the fifth motif position in TIS11d (E157) is observed in 
patients with bladder, breast, liver and lung carcinomas102. Mutations associated with the 
adenine-coordinating residues in ZF1 are detrimental to TIS11d (TTP) RNA binding 
activity. Our work suggest that mutations of the conserved R(K)YKTEL motif in ZF1 
decrease the affinity of TIS11d for its targets thereby impeding its activity and ultimately 
resulting in cancerous phenotypes.   
 
Materials and Methods 
 
Sample preparation for NMR 
WT TTP, WT TIS11d, E157R, E195K, and E157R/E195K were cloned, expressed and 
purified similar to Chapter II. TTPK was subcloned into a modified pGEX6P1 vector 
minus coding region for GST tag. To simplify the purification process the His tag in the 
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MHHHHHHGLEVLFQGPLGS tag was not removed. TTPK was expressed and lysed 
similar to Chapter II. Lysates were centrifuged at 19500 RPM for 1 hr at 4°C and passed 
through a 20 mL pre-packed PrepEase His Tagged resin (Affymetrix), washed with 5 
column volumes of 50 mM Tris HCl, pH 8.0, 50 mM NaCl, 5 mM imidazol, and eluted 
with 50 mM Tris HCl, 5 pH 8.0, 50 mM NaCl, 350 mM imidazol. The protein was then 
passed through a 5 mL HiTRAP Q (GE health are Life Science) pre-equilibrated with a 
buffer containing 50 mM Tris HCl, pH 8.0, 50 mM NaCl. Flow through was buffer 
exchanged into 10 mM Tris, pH 6.2, 20 mM KCl, 2 mM DTT, 0.1 mM ZnSO4 by 
dialysis and concentrated to using a 3 KDa Centriprep concentrator (Millipore). 
 
Sample preparation for FP assays 
The RBD of human TIS11d (residues 152-220) was synthesized by Genescript and 
cloned into the pHMTC vector between BamHI and HindIII restriction sites. Constructs 
containing arginine/lysine mutations in TTP and TIS11d were generated using the 
QuikChange Site-Directed Mutagenesis Kit from Stratagene. TIS11d and mutated 
constructs were expressed in BL21 (DE3) E. coli competent cells.  Isotopic labeling with 
15N was performed by growing the cells in M9 enriched with 1 g of 15NH4Cl per liter.  
Carbon labeling is performed by growing cells in M9 containing 13C-glucose. The cells 
were grown at 37°C to an OD600 of 0.8 and then induced for 4 hours with 1 mM Isopropyl 
β-D-1 thiogalactopyranoside (IPTG) and 0.1 mM ZnSO4 at the same temperature. 
Harvested cells were then passed through a cell disrupter in 50 ml lysis buffer containing 
50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 µM ZnOAc, 2 mM dithiothreitol (DTT) 
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and 1 EDTA free Complete protease inhibitor tablet (Roche).  Lysate was centrifuged at 
19500 RPM for 1hr at 4°C and passed through a 20 ml Amylose column pre-equilibrated 
with wash buffer (50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 µM  ZnOAc and 2 mM 
DTT). The column was washed with 10 column volumes of wash buffer. The protein was 
eluted with 10 mM Maltose in wash buffer. The eluent was then placed over a 5 ml Hi 
TRAP Q column (GE healthcare Life Science) pre-equilibrated with the same wash 
buffer used above. The column was washed with 3 column volumes of wash buffer. The 
protein was eluted with a gradient of NaCl from 0-1 M; the peptides typically eluted at 
0.3-0.5 M NaCl. Fractions containing our protein were combined, concentrated and 
dialyzed in 50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 µM ZnOAc and 2 mM DTT.  
 
Measurements of RNA-binding affinity 
The RNA-binding activity of the MBP tagged protein samples was determined using 
fluorescent polarization with fluorescein 5′ end labeled RNA as previously described 
Briefly, the affinities of TTP and TIS11d for variants of the cognate RNA sequence: 5′-
UUUUAUUUAUUUU-3′ (ARE13) were measured by direct titration of 3 nM labeled 
RNA with increasing concentrations of protein. Varying concentrations of the protein 
were incubated for 3 hours at room temperature with 3nM fluorescently labeled RNA in a 
buffer solution containing 10 mM TRIS (pH 8), 100 μM Zn(OAc)2, 100 mM NaCl, 0.01 
mg tRNA, 0.01% (v/v) IGEPAL, and  2 mM TCEP. To detect the fluorescently labeled 
RNA, the gel was imaged using a Fuji FLA-5000 laser imager. The apparent dissociation 
constant Kd,app was determined by fitting to the quadratic equation 
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𝑓 =
𝑚−𝑏
2𝑅
(𝐾𝑑 + 𝑃 + 𝑅 − √[𝐾𝑑 + 𝑃 + 𝑅]2 − 4𝑅𝑃) + 𝑏, 
where m and b are the maximum and base signals, Kd is the dissociation constant, and P 
and R are the concentrations of protein and labeled RNA in the sample, respectively. The 
reported data was done in triplicate.  
 
NMR spectroscopy  
All 15N-1H HSQC experiments were collected on a Varian Innova spectrometer operating 
at 600 MHz equipped with a triple-resonance cold probe. The temperature was calibrated 
using a sample of 100% methanol. Data processing was performed using NMRPipe 145 
and Sparky software146. The chemical shift differences, Δ, were determined using Δ = 
(δH2 +  (δNγN/γH)2)1/2, where δH is the chemical shift difference of  1H, δN is the chemical 
shift difference of 15N and γN, γH are the gyromagnetic ratio of 1H and 15N atoms. 
 
Luciferase reporter assay 
The pcDNA3.1 His-C-TTP (TTP) expression construct was kindly given to us by Dr. 
Seth Brooks48. C162S, E107R, E145K, and E107R/E145K mutantions of TTP was 
generated using Q5-mutagenesis kit (NEB). Luciferase reporter constructs harboring 
cDNA of TNF 3′UTR (nucleotides 1,231-1,506) was generated by gblock synthesis 
(IDT) and was inserted into the psicheckTM-2 construct at restriction sites XhoI and NotI.  
Human embryonic kidney (HEK) 293 cells were plated at a density of 300,000 cells/well 
in 6 well plates, with Dulbecco′s Modified Eagle′s Medium (DMEM) containing 100 
units/mL penicillin and 100 µg/mL streptomycin and 10% fetal bovine serum (FBS). The 
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plates were incubated for 24 hours in a humidified 5% CO2 incubator set at 37 C. When 
the cells were 60-70% confluent each well was cotransfected with 0.25 µg 
psicheck2_TNFalpha and 0.5 µg of pcDNA3.1-His-C (empty plasmid), pcDNA3.1 TTP, 
pcDNA3.1 TTP (E107R), , pcDNA3.1 TTP (E145K), pcDNA3.1 TTP (E107R/E145K), 
or pcDNA3.1 TTP (C162S) using Dharmafect Duo protocol (Thermo-Scientific). 
Transfections were performed in triplicate. 48 hours after transfection, cells were 
harvested and Luciferase activity was monitored using a Dual-luciferase Reporter Assay 
System (Promega) and normalized by the internal control values given by firefly 
luciferase. Luciferase activity was monitored in each well 3 times.  
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Chapter IV: Three residues make an evolutionary switch for 
folding and RNA-destabilizing activity in the  
TTP family of proteins 
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Abstract 
 Tristetraprolin (TTP) binds to mRNA transcripts to promote their degradation. 
The TTP protein family in humans includes two other proteins, TIS11b and TIS11d. All 
three proteins contain a highly homologous RNA binding domain (RBD) that consists of 
two CCCH zinc fingers (ZFs). Both ZFs are folded in the absence of RNA in TIS11d and 
TIS11b. In TTP, however, only ZF1 adopts a stable fold. The focus of this study is to 
understand the origin and biological significance of the structural differences of the RBD. 
We identified three residues that affect the affinity for the structural Zn2+ and determine 
the folding of ZF2 in the absence of RNA. We observed that the mRNA destabilizing 
activity of TTP was increased when the partially disordered RBD of TTP was replaced 
with the fully structured RBD of TIS11d, indicating that differences in the folded state of 
the RBD affect the activity of the proteins in the cell. 
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Significance 
 Despite the importance of RNA-binding proteins to gene regulation, our 
understanding of how their structure and dynamics contribute to their biological activity 
is limited. In this study we focus on two related RNA-binding proteins—TTP and 
TIS11d—that regulate the stability of mRNA transcripts encoding key cancer-related 
proteins, such as tumor necrosis factor- and vascular endothelial growth factor. These 
two proteins display differential folding propensity in the absence of RNA, despite 
sharing a high sequence identity. Here we identified three residues located at the C-
terminal end of an -helix that determine the folding propensity of the RNA-binding 
domain in the apo state. We also showed that stabilization of the structure of the RNA-
binding domain is associated with increased RNA-destabilizing activity. Phylogenetic 
analysis indicates that this family of proteins has only recently evolved to be able to 
modulate its biological activity through its dynamic structure. 
Introduction 
Tristetraprolin (TTP), also known as TIS11, Nup475, GOS24, and ZFP3655,100,154-158, is 
an RNA binding protein that binds to the 3′ UTR of transcripts at AU-rich elements 
(AREs)159. Binding of TTP to these transcripts promotes their fast degradation, as TTP 
recruits and activates mRNA decay enzymes60,160,161. The function of TTP became 
apparent with the observation that TTP knockout mice quickly develop severe 
inflammatory phenotypes after birth, a result of the accumulation of several transcripts67. 
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The most abundant of these transcripts encodes the proinflammatory cytokine tumor 
necrosis factor  (TNF)55. 
 In humans, the TTP protein family includes TIS11b and TIS11d, also known as 
ZFP36L1 and ZFP36L2118,126, respectively. Based on their primary sequences, these three 
proteins are predicted to have low structural complexity and high flexibility. They each 
contain an RNA binding domain (RBD), surrounded by less-structured N- and C-terminal 
domains. The highly conserved RNA binding domain is a tandem zinc finger (TZF) motif 
with two CX8CX5CX3H zinc fingers, where X represents amino acids between each zinc 
coordinating residue. The two zinc fingers are separated by an 18 amino acid linker. A 
well conserved sequence, (R/K)YKTEL, precedes each finger and has been shown to be 
important for RNA binding118,128,162.  
 In 2004, Wright and coworkers determined the structure of TIS11d bound to the 
RNA sequence 5′-UUAUUUAUU-3′ (PDB code:1RGO) using NMR spectroscopy127. 
This structure depicts two folded zinc fingers where the zinc ions are coordinated by 
residues C159, C168, C174, and H178 in the first finger (ZF1) and C197, C206, C212, 
and H216 in the second finger (ZF2). The protein-RNA complex shows that the structure 
of the TZF domain of TIS11d is symmetrical, both ZF1 and ZF2 contain a short -helix 
between the first two zinc coordinating cysteine residues (spanning residues 160-165 in 
ZF1 and 198-203 in ZF2). Additionally, both fingers contain a turn of 310-helix between 
the second and third cysteine-coordinating resides (amino acids 171-173 in ZF1 and 209-
211 in ZF2). The symmetry observed between the structures of the two zinc fingers is not 
surprising since their primary sequence is ~50% identical. The two zinc fingers are held 
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together by a flexible linker, which contains a short 310-helix at residues 179-183 and is 
involved in forming a small hydrophobic cluster with residues of the first finger.  
NMR and computational studies have shown that in the absence of RNA, the structure of 
the two zinc fingers of TIS11d is maintained although their orientation changes, as the 
linker region is highly flexible127,128,162. Despite their high sequence identities, TTP and 
TIS11d present striking differences in their unliganded structures. The structural 
symmetry observed for ZF1 and ZF2 in TIS11d is not observed in unliganded TTP. 
Previous NMR spectroscopic studies of TTP indicated that only ZF1 of TTP may adopt a 
stable fold in its RNA free state163,164.  
 The focus of this study is to understand the origin and biological significance of 
the structural differences observed between the RNA binding domains of TTP and 
TIS11d. We used TTP/TIS11d chimeras to identify the regions responsible for these 
differences. After testing whether these chimeras are still active and capable of binding 
RNA, we used NMR spectroscopy to determine if ZF2 is folded in the free state. Finally, 
we determined how a fully folded TZF domain affects the activity of TTP using a 
luciferase reporter assay, where luciferase was placed under the control of the TNF 
3′UTR. The results reveal that the degree of structure of the RBD affects the activity of 
these proteins in the cell. 
 
Results and Discussion 
Despite the importance of RNA-binding proteins to gene regulation, our 
understanding of how their structure and dynamics contribute to their biological activity 
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is limited. In this study we focus on two related RNA-binding proteins—TTP and 
TIS11d—that regulate the stability of mRNA transcripts encoding key cancer-related 
proteins, such as tumor necrosis factor- and vascular endothelial growth factor. TTP and 
TIS11d display differential folding propensity in the absence of RNA, despite sharing a 
high sequence identity. To understand the origin of the different folding propensities and 
how the activities of the two proteins are affected, we used an interdisciplinary approach 
that included biochemical and biophysical methods, cell-based assays and phylogenetic 
analysis.  
The TZF domains of TTP and TIS11d share high sequence identity but differ in their 
RNA-free structures. 
Although the TZF domains of TTP and TIS11d share 70% sequence identity, we observe 
that their solution structures differ dramatically in the apo state. The well-dispersed 15N-
1H HSQC spectra of the TZF domains of TIS11d (residues 151-220) and TIS11b 
(residues 200-270) indicate that the structures of both ZF1 and ZF2 are preserved  
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Figure 4.1. The C-terminal ZF of TTP is unstructured in the free state. A) 15N-1H HSQC spectra of the 
TZF domains of TTP (red), TIS11d (blue) and TIS11b (green). B) Sequence alignments of TZF domains of 
TTP, TIS11d, and TIS11b. Sequence differences between TTP, TIS11d and TIS11b are highlighted in red. 
Residues with cross-peaks present in the 15N-1H HSQC spectrum of TTP collected in the absence of RNA 
are highlighted in yellow.  
 
in the absence of RNA (Figure 4.1). In contrast, the 15N-1H HSQC spectrum of the TTP 
TZF domain (residues 102-174) contains only cross peaks from residues of ZF1 and from 
the first nine residues of the linker (Figure 4.1 and Figure 4.2). The lack of backbone 
amide (N-HN) cross peaks for ZF2 from the spectrum of TTP in the absence of RNA is 
the result of a chemical exchange process that is intermediate on the NMR chemical shift 
time scale, likely due to the flexibility of ZF2 that samples different 
conformations115,165,166. Cross-peaks from the C-terminal part of the linker and from ZF2 
appear in the 15N-1H HSQC spectrum of TTP only upon addition of RNA (Figure 4.3A). 
The overall increase in chemical shift dispersion observed upon addition of RNA results 
from the increased number of cross-peaks (cross-peaks from the linker and ZF2 are now 
present in the 15N-1H HSQC spectrum) and from the chemical shift changes of ZF1, due 
to RNA-binding. These data suggest that in the absence of RNA, ZF2 of TTP is in a 
molten globule state and that RNA is needed to stabilize ZF2 in a folded state, in 
agreement with the findings of Brewer et al.167. In a previous study, Berg and coworkers 
have shown that the TZF domain of murine TTP could bind 1.7 ± 0.4 equivalents of Co2+ 
26 which suggests that both ZF1 and ZF2 of murine TTP can bind Zn2+ in the absence of 
RNA. In the same report, however, NMR spectroscopic studies of the TZF domain of 
murine TTP containing a single point mutation introduced to enhance solubility (Y143K), 
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showed that only ZF1 could stably bind Zn2+ while ZF2 was unstructured168, in 
agreement with our observations in human TTP.  
 
Figure 4. 2. 15N-1H 2D HSQC spectra of TIS11d and TTP. 15N-1H HSQC spectra of TIS11d and TTP are 
shown in blue and red, respectively.  The resonance assignments are indicated on each spectrum. 
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Figure 4.3. In TTP ZF2 is unstructured in the unbound state but folds upon RNA-binding. a) 15N-1H 
HSQC spectra of RNA free (red)/RNA bound TTP (gray). New cross-peaks, corresponding to residues of 
the linker and ZF2 of TTP, appear upon addition of RNA. The structural transition occurring upon RNA-
binding is depicted on top. The 3D structure of TTP was modeled from that of TIS11d (PDB id: 1RGO)19. 
b) Far-UV circular dichroism (CD) spectra of TTP (red), TIS11d (blue) and TIS11b (green). The CD 
spectra of TIS11b and TIS11d are almost entirely overlapped. 
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Due to chemical exchange line broadening, cross-peaks from ZF2 are absent in the 15N-
1H HSQC spectrum of TTP, thus no structural information can be determined for this part 
of the domain using NMR spectroscopy. In order to test the hypothesis that ZF2 is in a 
molten globule state, we used several experimental approaches, including mutagenesis, 
CD spectroscopy and metal analysis, where we estimated the [Zn2+]/[TZF] ratio for both 
TTP and TIS11d.  
 
Figure 4.4. 15N-1H HSQC spectra of TTP, C162S TTP mutant, TIS11d and C212S TIS11d mutant. 
Left: Overlay of 15N-1H HSQC spectra of TTP (red) and C162S TTP mutant (black), whose C-terminal ZF 
cannot fold due to a missing Zn-coordinating Cys residue. Right: Overlay of 15N-1H HSQC spectra of 
TIS11d (blue) and C212S TIS11d mutant (black), whose C-terminal ZF cannot fold due to a missing Zn-
coordinating Cys residue shows that only the N-terminal ZF of the mutant protein adopts a stable fold. On 
top, a schematic representation of the TZF domain shows the zinc fingers as rectangles and the linker as 
line. The black X is representative of the cysteine zinc coordinating residue that is mutated in this 
experiment. The dots indicate residues along the sequence with a cross-peak in the 15N-1H HSQC spectrum. 
 
 NMR spectroscopy was used to determine the effect of a single point mutation, 
the third zinc-coordinating Cys to Ser, on the structure of TTP and TIS11d: C162S and 
C212S in TTP and TIS11d, respectively. These mutant proteins are lacking one of the 
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zinc-coordinating Cys residues in ZF2, thus ZF2 cannot stably bind Zn2+ and fold (Figure 
4.4). The 15N-1H HSQC spectra of wild-type (WT) TTP and C162S mutant TTP are 
nearly identical (Figure 4.4), with the exception of a few cross-peaks originating from 
presence of four extra residues at the C-terminus of the C162S mutant construct used. 
The 15N-1H HSQC spectrum of C212S TIS11d resembles that of wild-type TTP, as cross-
peaks from the unstructured ZF2 are missing (Figure 4.4). These results support the 
hypothesis that in the absence of RNA, ZF2 of TTP cannot stably bind Zn2+. As a result, 
ZF2 of TTP samples many partially structured states on a time-scale that is intermediate 
relative to the chemical shift differences, thus cross-peaks from ZF2 are broadened 
beyond detection24. In addition, these mutant proteins showed that in both TTP and 
TIS11d, ZF1 can independently adopt a stable fold when ZF2 is unfolded (Figure 4.4). 
 The CD spectra of TTP, TIS11b and TIS11d show that the TZF domain of TTP is 
less structured than that of TIS11d and TIS11b, as evidenced by the difference in CD 
signal peak intensities between 220-240 nm (Fig. 4.3B). In addition, Zn2+ titrations of 
TIS11d and TTP, monitored by CD spectroscopy, show that TIS11d coordinates two 
equivalents of Zn2+, one ion for each finger. TTP, however, only coordinates one zinc 
cation, indicating that ZF2 is disordered in solution (Figure 4.5). The same result was 
obtained when the [Zn2+]/ [TZF] ratio was determined for both TTP and TIS11d using 
inductively coupled plasma-optical emission spectrometry (ICP-OES), [Zn2+]/[TIS11d] = 
1.8 ± 0.1 and [Zn2+]/[TTP] = 1.1 ± 0.1. 
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surprising considering that engineered zinc fingers constructed from the same amino acid 
sequence except for the Zn2+ coordinating residues (Cys4, Cys3His and Cys2His2 were 
tested) have similar affinity for Zn2+169,171. These and our results indicate that differences 
in Zn2+ binding affinity arise not primarily from the particular atoms that coordinate the 
Zn2+, the first solvation shell, but mostly from the second coordination sphere27. Thus, the 
particular primary, secondary and tertiary structures of a protein determine the affinity for 
Zn2+ of the zinc finger. 
  
The predicted secondary structure for ZF1 of TTP is the same as that observed for ZF1 
of TIS11d. 
 Small backbone chemical shift differences are observed for ZF1 and the linker of 
TTP and TIS11d, suggesting that ZF1 of these two proteins have similar structures 
(Figure 4.6). This is not surprising since ZF1 of TTP and TIS11d (159-179 TIS11d/109-
129 TTP) share 81.5% sequence identity. To support this conclusion, the backbone 
resonances of TTP (C, Cβ, CO, N, and HN) were used to predict the secondary structure 
elements of ZF1 using δ2D software172,173. The predicted secondary elements are the 
same as those observed in the solution NMR structure for TIS11d. To understand how the 
primary sequence of ZF1 affects the observed chemical shifts, the residues that differ 
between TIS11d and TTP were mutated in TIS11d and chemical shift perturbations were 
calculated (Figure 4.6). From this data we determined that many differences observed 
between the spectra of TTP and TIS11d ZF1 arise from the identity of one residue, P161 
in TIS11d and T111 in TTP. In TIS11d, this proline is in a short α-helix (residues 160-
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Identifying the origin of the difference in structures of TTP and TIS11d using 
chimeras.  
Many of the residues that differ between the TZF motif of TTP and TIS11d span the 
length of the motif, thus it is not easy to identify the residues that stabilize the structure of 
ZF2 from a simple analysis of the primary sequence. For this reason, chimeric proteins 
were constructed by combining the linker and/or zinc fingers of TTP and TIS11d to 
identify the role that different residues have in determining the structure of the zinc 
fingers (Figure 4.7). Folding of each chimera was monitored using NMR spectroscopy to 
detect structural changes from the wild-type proteins with residue resolution. The absence 
of N-HN cross peaks for the residues of ZF2 and part of the linker from the 15N-1H HSQC 
spectrum, due to intermediate exchange line broadening, is an indication of lack of 
structure or partial folding of ZF2 (Figure 4.7). From the data we can conclude that 
switching the linkers of TTP and TIS11d does not affect the structure of ZF2. However, 
the primary sequence of ZF2 affects its structure. Replacing the primary sequence of ZF2 
of TTP with that of TIS11d increases the number of resonance peaks observed in the 
spectrum, with these cross-peaks corresponding to the C-terminal half of the domain that 
now folds into a stable structure. The converse is also true: changing the primary 
sequence of TIS11d ZF2 into that of TTP increases the propensity for intrinsic disorder of 
the chimera, and cross peaks from ZF2 are broadened beyond detection in the 15N-1H 
HSQC spectrum. Altogether, these findings show that the primary sequence of ZF2 alone 
determines its structure or lack thereof. 
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Figure 4.7. 1H-15N HSQC spectra of TTP/TIS11d chimeras. Backbone amide cross peaks represented 
for TTP (red), TIS11d (blue), and chimeras (black). A schematic representation of the TZF domain (amino 
acid sequences from TIS11d and TTP shown in blue and red, respectively) and the residues that have a 
cross-peak in the 15N-1H HSQC (represented by dots) is depicted on top of each spectrum. Lack of amide 
cross peaks is due to chemical exchange process that is intermediate on the chemical shift time scale 
resulting from the flexibility of the unstructured ZF2.  
All TTP/TIS11d chimeras bind to the ARE13 sequence with similar affinities. 
 To determine if the chimeras retain RNA binding activity, we determined the 
equilibrium dissociation constant of each chimera using fluorescent electrophoretic 
mobility shift assays174. All of the chimeras bind to a model ARE sequence (ARE13: 5′-
UUUUAUUUAUUUU-3′) with similar affinity, indicating that the folded/unfolded 
character of the second zinc finger does not strongly affect the RNA binding activity of 
the protein, Table 4.1. Analysis of the primary sequence shows that TTP has a net charge 
of 8.2, while TIS11d has a net charge of 3.3 at pH 7 (Innovagens - peptide properties 
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calculator, http://www.innovagen.com/custom-peptide-synthesis/peptide-property-
calculator/peptide-property-calculator-notes.asp). The more basic nature of TTP may 
result in enhanced attractive Coulomb interaction with the RNA and a more favorable 
enthalpy of binding thus compensating for the entropic penalty associated to folding of 
ZF2 upon RNA binding. This entropy-enthalpy compensation in the free energy of RNA-
binding was observed for TIS11d and a mutant of TIS11d where residues D219 and E220 
were deleted, thus changing the total net charge of the TZF domain175.  
Table 4.1. Table of the RNA binding activity of TTP/TIS11d chimeras. Electrophoretic mobility shift 
assays (EMSA) with labeled ARE13 were used to determine the RNA binding activity of each chimera, all 
chimeras are active. Each of the chimera is made by fusing ZF1, the linker, or ZF2 from either TTP (red) or 
TIS11d (blue). Left is a representative gel shift for TIS11d binding to ARE13.  
 
 
Understanding how the amino acid composition of ZF2 determines the unfolded/folded 
character of the zinc finger. 
 We found that the primary sequence of ZF2 determines the structure of ZF2. In 
order to dissect what accounts for a stably folded ZF2, we made mutations within the 
second zinc finger where residues of TIS11d were mutated to the equivalent residues in 
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TTP (Figure 4.8 and Figure 4.9). Most of the differences in amino acid sequence between 
TTP and TIS11d ZF2 are observed in the region that is helical in TIS11d117 (Figure 4.1). 
Mutation of the residues of this region of TTP (residues 148-155) into those of TIS11d 
(residues 198-205) results in the presence of cross-peaks from ZF2 and the second half of 
the linker in the 15N-1H HSQC spectrum, indicating that ZF2 is now stably folded (Figure 
4.8, top). Furthermore, mutation of the residues in the second half of the -helix of 
TIS11d (residues H201, T202 and I203) to those of TTP (residues Y151, L152, Q153) 
results in loss of signal from almost all residues of ZF2 and the second part of the linker 
(Figure 4.8, bottom), indicating loss of structure in ZF2. Mutating the first two residues 
of the -helix (R198 and T199) of TIS11d to those of TTP does not affect the structure of 
ZF2 (Figure 4.9).  There are two other residues that are different between ZF2 of TIS11d 
and TTP (Figure 4.1): F205 and P210. Mutation of F205 to R and of P210 to S in TIS11d 
did not change the structure of the finger indicating that these two residues do not affect 
the stability of ZF2 (Figure 4.9).  
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 We also investigated how the C-terminal tail of the TZF domain (Figure 4.1) 
affects the overall stability of ZF2. Previous experimental and molecular dynamics (MD) 
Figure 4.8. Helicity differences are responsible for the difference in fold observed for TTP and 
TIS11d.  (Top) Overlay of the 1H-15N HSQC spectrum of WT TTP (red) with that of the mutant protein 
containing the TIS11d amino acid sequence at the -helical region of ZF2, residues 148-153, (black). 
(Bottom) Overlay of the 1H-15N HSQC spectrum of  WT TIS11d (blue) with that of the mutant protein 
containing the TTP amino acid sequence at the second half of the -helical region of ZF2, residues 200-
203, (black). On top, a schematic representation of the TZF domain shows the zinc fingers as rectangles 
and the linker as line. The dots indicate residues along the sequence with a cross-peak in the 1H-15N HSQC 
spectrum.  
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studies of TIS11d have shown how the two conserved negatively charged residues 
flanking ZF2 (D219 and E220) contribute to the stabilization of the TZF structure 
through their electrostatic interaction with the positively charged residues of the linker 
and that disruption of these interactions results in a more flexible but still folded 
ZF2175,176. Here we show that mutation of A218 and D219 in TIS11d to the corresponding 
residues of TTP (P168 and S169, respectively) result in the disappearance of a few cross-
peaks in the linker (188-189) and in ZF2 (216-219), Figure4.9. In agreement with our 
previous studies117,176, this result indicates that the residues of the C-terminal tail affect 
the dynamics of the linker region and those of ZF2 but do not affect its folding.  
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shown) for TTP bound to RNA (ARE13: 5′-UUUUAUUUAUUUU-3′), from the 
backbone and C chemical shifts using δ2D173 and SPARTA+177 software, shows that the 
-helix between the first two zinc coordinating cysteine residues in ZF2 is shorter in TTP 
(residues 148-150) than what is observed in TIS11d (residues 198-203). Our experimental 
results support the recent computational model of TTP bond to RNA bound developed by 
Blackshear and coworkers178. These computational studies suggested that while TIS11d 
forms two alpha helical turns in this region, TTP only forms one helical turn. Taken 
together these studies indicate that the ability to form a longer -helix affects the ability 
of the finger to stably coordinate the Zn2+ ion and fold into a unique structure in the 
absence of RNA.  
Comparative genomics 
Comparison of the amino acid sequences of TIS11d and TTP from vertebrates 
from 100 species179-182 (Figure 4.10) indicates that the TZF domain of TIS11d is likely 
always folded, as the three residues of the -helix that alone stabilize the structure of ZF2 
(residues 201-203, HTI) are absolutely conserved. In TTP homologs, however, the 
corresponding three residues (res. 151-153, YLQ, associated with the disorder of the TZF 
domain) are only conserved in mammals (Figure 4.10). In fish, reptiles, amphibians and 
birds these three residues are the same as in TIS11d, thus, from our studies (Figure 4.8), 
we predict that ZF2 is folded in these vertebrates. Comparative genomics suggests that 
TTP has evolved more recently in mammals to modulate its folding through Zn2+ and 
RNA binding. In addition, we observed that the presence of the HTI amino acids, which 
stabilize the structure of ZF2 (Figure 4.8), correlates with the presence of two acidic 
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amino acid residues at the tail of the TZF domain (Figure 4.10). Our previous studies 
have shown that these two acidic residues are important to stabilize the structure of the 
folded TZF domain of TIS11d in an RNA-binding competent state117. These data suggest 
that they are not conserved when ZF2 is unstructured. 
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Figure 4.10. Sequence alignment of the TZF domain of TIS11d and TTP. Sequence alignment of the 
TZF domain of TIS11d (top) and TTP (bottom) taken from 100 vertebrate species. The alignment was 
generated from the Genome browser (http://genome.ucsc.edu/). The three residues located at the C-terminal 
half of the -helix of ZF2, that alone determine the structure or lack of structure of ZF2, are highlighted by 
a red box. Additional residues flanking the TZF domain that are important for stabilizing TIS11d ZF2 are 
shown in red.  A schematic representation of the TZF domain depicting the zinc fingers as rectangles and 
the linker as line is shown on top.  
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Determining the effect of the structure of the TZF domain on the cellular activity of 
TTP.  
  To determine whether the structure of the TZF domain of TTP affects its mRNA 
destabilizing activity in cells, we employed a reporter assay where luciferase was placed 
under the control of the TNF 3′UTR. HEK293 cells (which do not express TTP 
constitutively) were co-transfected with a plasmid containing full length TTP or chimeric 
variants and a plasmid encoding both Renilla and firefly luciferase. The Renilla luciferase 
gene was fused to the 3′UTR sequence of TNF, while the firefly luciferase was fused to 
a control vector 3′UTR. The ratio of Renilla to firefly luciferase reveals TTP variant 
activity normalized by transfection efficiency. Differences in luciferase activity observed 
between cells that expressed wild-type TTP or TTPTZF_TIS11d fusion protein, where the 
TZF domain of TTP has been replaced with that of TIS11d, assess the degree to which 
intrinsic disorder of the TZF domain affects the regulatory activity of the protein. The 
TTPTZF_TIS11d fusion protein, which has a stably folded ZF2, led to a two-fold reduction in 
luciferase activity compared to wild-type TTP (Figure 4.11). Having a structured ZF2 
decreased the expression of the protein in cells (decreased luciferase activity), therefore, 
the TTPTZF_TIS11d fusion protein has higher activity than WT TTP (Figure 4.11). As 
expected, high luciferase activity was observed when the cells were transfected with a 
plasmid containing the mutant protein C162S of TTP, where the third zinc-coordinating 
cysteine has been mutated to a serine in ZF2 and thus cannot fold even in the presence of 
RNA (Figure 4.11). Although we expected C162S TTP to be completely inactive, a 
residual mRNA destabilizing activity was observed for this mutant protein. This residual 
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activity has been previously observed,183 suggesting that mutation of the zinc-
coordinating residues in ZF1 might be necessary to completely inactivate the protein. 
Together, the results show that the mRNA destabilizing activity of TTP in the cell is 
affected by the structure of ZF2 in the RNA binding domain, and increasing the structure 
of the TZF domain of TTP increases the RNA-destabilizing activity of the protein in the 
cell. 
 
Figure 4.11. Measurements of the cellular activity of TTP and TTP/TIS11d chimeras. The structure of 
the TZF domain of TTP affects the mRNA destabilizing activity of TTP in HEK293 cells. The plot shows 
the relative luciferase activity measured for HEK cells incubated for 48 hours with empty pcDNA3.1HISC 
plasmid, WT TTP, TTP chimera (TTP containing the TZF domain of TIS11d, TTPTZF TIS11d), and TTP 
C162S mutation.   
 There are several possible explanations for this observation. 1) Disorder in the 
TFZ domain may trigger TTP degradation, lowering its cytoplasmic concentration184. 2) 
The cytoplasmic concentration of TTP may also be decreased by an increased import into 
the nucleus. The nuclear transport protein importin has been shown to bind to the basic 
 
 
 114 
residues R134 and R137 of the linker region of the TZF185, thus the structure of ZF2 
might affect the recognition and transport of TTP into and out of the nucleus. 3) The 
structure of the TZF domain may affect how the protein interacts with other enzymes of 
the RNA degradation machinery124. 4) A fully structured TZF domain may increase the 
RNA-binding affinity in cells. Any or all of these explanations may account for the 
increased cellular activity associated with a fully folded RNA binding domain. 
Differential folding propensities of ZFs may explain observations of TZF proteins in 
other species, as well. The CCCH-type TZF domain of the TTP family of protein was 
first identified in the murine TTP163, and has since been found in more than 3600 
proteins186. Analysis of the C. elegans genome has revealed the presence of an unusually 
high number of proteins (16) containing a TZF domain homologous to TTP. Several of 
these proteins (OMA-1, OMA-2, MEX-5, MEX-6, PIE-1, POS-1 and MEX-1) have a 
known function as mRNA regulators at the onset and during the early stages of 
embryogenesis187. Experimental evidence indicates that the two zinc fingers of these TZF 
domains play different functions during embryogenesis188. While the N-terminal zinc 
finger of POS-1, PIE-1 and MEX-1 has been demonstrated to be necessary and sufficient 
for degradation in somatic blastomeres, the C-terminal zinc finger is necessary and 
sufficient to target these proteins to P granules, which are germline cytoplasmic structures 
rich in RNA45. These findings suggest that the two fingers in the CCCH-type TZF 
domain may function independently and that the structure, or lack thereof, of each finger 
might affect the activity and/or localization of the protein within the cell. This 
independence may apply to the human TZF domains of the TTP family, thus the 
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increased propensity for intrinsic disorder of TTP relative to TIS11b and TIS11d may 
indicate that the proteins have evolved to be able to modulate their activity through their 
thermodynamic stability. 
Summary 
 In conclusion, our studies reveal 1) that the three residues located in the -helical 
region of ZF2 alone determine if the TZF domain is fully or partially folded, 2) that the 
degree of structure of the TZF domain affects the activity of the protein in the cell and 3) 
this family of proteins has only recently evolved to be able to regulate its activity through 
modulation of its folding. It will be interesting to determine whether the structural 
disorder of the TZF domain affects binding partner recognition in the cell, cellular 
stability and localization, or all the above. 
Methods 
Protein expression and purification 
The RBD of human TTP (residues 102-170) and TIS11d (residues 152-220) was 
synthesized by Genscript and cloned into the pet21b vector between Nde1 and Xho1 
restriction sites. Chimeras of TTP and TIS11d were generated via Quikchange 
mutagenesis. TTP, TIS11d and chimeras were expressed within BL21(DE3) E. coli 
competent cells. Isotopic labeling with 15N was performed by growing the cells in M9 
enriched with 1 g of 15NH4Cl per liter. Carbon labeling was performed by growing cells 
in 13C-glucose. The cells were grown at 37° C to an OD600 of 0.8 and then induced for 4 
hours with 1 mM Isopropyl β-D-1 thiogalactopyranoside (IPTG) and 0.1 mM ZnSO4 at 
the same temperature. Harvested cells were passed through a cell disrupter in 50 mL lysis 
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buffer containing 50mM Tris HCl, pH 8.0, 50 mM NaCl, 2 mM dithiothreitol (DTT) and 
1 EDTA free Complete protease inhibitor tablet (Roche). Lysates were centrifuged at 
19500 RPM for 1 hr at 4° C and passed through a 20 mL DEAE column pre-equilibrated 
with 50 mM Tris HCl, pH 8.0, 50 mM NaCl and 2 mM DTT. The flow through was 
dialyzed overnight in 25 mM sodium phosphate, pH 6.5, 50 mM NaCl and 2 mM DTT 
and passed through a HiTRAP SP 10mL column (GE healthcare Life Science) 
preequilibrated with 25 mM sodium phosphate, pH 6.5, 50 mM NaCl and 2 mM DTT. 
The peptides were eluted with a gradient of NaCl from 0-1 M; the peptides typically 
eluted at 0.2-0.6 M NaCl. Fractions with peptide were combined and concentrated to 2 
mL using a 3 KDa Centriprep (Millipore) and further purified using a 1.6 X 60 cm 
Superdex-75 size exclusion column (Amersham Bio\sciences) equilibrated with 50 mM 
Tris HCL pH 7, 300 mM NaCl, 2 mM DTT. For NMR analysis fractions with TTP, 
TIS11d or chimeras were buffer exchanged into 10 mM Tris pH 6.2, 20 mM KCl, 2 mM 
DTT, 0.1 mM ZnSO4. Protein concentrations were determined via Ninhydrin assay.  
 
Measurements of RNA-binding affinity 
The RNA-binding activity of the samples was determined using fluorescent 
electrophoretic mobility shift assays (EMSA) with fluorescein end labeled RNA as 
previously described4. Briefly, the affinities of TTP, TIS11d, and chimeras for the 
sequence 5′-UUUUAUUUAUUUU-3′ (ARE13) were measured by direct titration of 3 nM 
labeled RNA with increasing concentrations of protein. Varying concentrations of the 
protein were incubated for 3 hours at room temperature with 2 nM fluorescently labeled 
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RNA in a buffer solution containing 10 mM TRIS (pH 8), 100 μM Zn(OAc)2, 100 mM 
NaCl, 0.01 mg tRNA, 0.01% (v/v) IGEPAL, and 2 mM DTT. After addition of 10 μL of 
0.005%(w/v) bromocresol green in 30% glycerol to 100 μL of each sample, 50 μL of 
each mixture were loaded onto a 1% agarose, 1Å~TB gel and run for 35 min at 120 V at 
room temperature to separate bound from free RNA. To detect the fluorescently labeled 
RNA, the gel was imaged using a Fuji FLA-5000 laser imager. The apparent dissociation 
constant Kd,app was determined by fitting to the quadratic equation31, 
𝑓 =  
𝑚−𝑏
2𝑅
(𝐾𝑑 + 𝑃 + 𝑅 − √[𝐾𝑑 + 𝑃 + 𝑅]2 − 4𝑅𝑃) + 𝑏, 
where m and b are the maximum and base signals, Kd is the dissociation constant, and P 
and R are the concentrations of protein and labeled RNA in the sample, respectively. 
 
NMR spectroscopy  
Three dimensional triple resonance (1H-13C-15N) experiments, including HNCO, 
HN(CA)CO, HNCA, HN(CO)CA, HNCACB, and CBCA(CO)NH, were collected at 14.1 
T and 298 K to assign the backbone 1H, 13C, and 15N resonances of [U-13C, U-15N] TTP 
and TIS11d in 92% H2O/8% D2O buffer solution (10 mM Tris, 20 mM KCl, 2 mM DTT, 
0.1 mM ZnSO4 at pH 6.2). Additional 3D 15N edited 1H–1H NOESY and HMQC-
NOESY-HSQC experiments were collected at 14.1 T and 298 K and used to aid in the 
backbone resonance assignment of the chimeras. 
 Folding of each chimera was monitored via NMR spectroscopy. 15N-1H HSQC 
spectra were collected at 298 K for each chimera. All NMR triple-resonance and 15N-1H 
HSQC experiments were collected on a Varian Inova spectrometer operating at 600 MHz 
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equipped with a triple-resonance cold probe. The temperature was calibrated using a 
sample of 100% methanol. Data processing was performed using NMRPipe 145 and 
Sparky software146. 
 
Sample Preparation for Trace Metal Analysis 
The RBD of human TIS11d (residues 152-220) and TTP (residues 102-170) were cloned 
into the pHMTC vector between BamHI and HindIII restriction sites. Constructs were 
expressed in BL21(DE3) E. coli competent cells. The cells were grown in Luria Broth 
(LB) media at 37°C to an OD600 of 0.6 and then induced for 3 hours with 1 mM IPTG and 
0.1 mM ZnSO4 at the same temperature. Harvested cells were then passed through a cell 
disrupter in 50 ml lysis buffer containing 50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 
µM ZnOAc, 2 mM DTT and 1 EDTA free Complete protease inhibitor tablet (Roche). 
Lysate was centrifuged at 19500 RPM for 1hr at 4°C and passed through a 20 ml 
Amylose column pre-equilibrated with wash buffer (50 mM Tris HCl, pH 8.0, 100 mM 
NaCl, 100 µM ZnOAc and 2 mM DTT). The column was washed with 10 column 
volumes of wash buffer. The protein was eluted with 10 mM Maltose in wash buffer. The 
eluent was then placed over a 5 ml Hi TRAP Q column (GE healthcare Life Science) pre-
equilibrated with the same wash buffer used above. The column was washed with 3 
column volumes of wash buffer. The protein was eluted with a gradient of NaCl from 0-1 
M; the peptides typically eluted at 0.3-0.5 M NaCl. Fractions containing our protein were 
combined, concentrated and dialyzed in 50 mM Tris HCl, pH 8.0, 150 mM NaCl, trace 
amounts of ZnOAc and 0.1% β-mercaptoethanol (BME), and protein concentrations were 
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determined by UV absorption. The concentration of Zn2+ in the samples was determined 
using inductively coupled plasma-optical emission spectrometry (ICP-OES) at the Center 
for Applied Isotope Studies at the University of Georgia. 
 
CD spectroscopy 
Far-UV circular dichroism (CD) spectra were recorded for TTP (50 M) and TIS11d (18 
M) in 50 mM HEPES pH 7.0, 20 mM KCl and 1 mM TCEP using a Jasco-810 
spectropolarimeter (Jasco Inc., Easton, MD). Curves were monitored from 200-260 nm in 
a 0.1 cm path length quartz cuvette using a scan rate of 20 nm min-1 and a response time 
of 8 s. The sample temperature for all CD measurements was maintained at 293 K.  
 
Luciferase reporter assay 
The pcDNA3.1 His-C-TTP (TTP) expression construct was kindly given to us by Dr. 
Seth Brooks159. The cDNA for the fusion protein containing the N- and C- terminal 
domain of TTP and the TZF domain of TIS11d was generated by Genscript and contained 
flanking EcoR1 restriction sites for subsequent cloning into pcDNA3.1 His-C-TTP. 
C162S mutant of TTP was generated using Q5-mutagenesis kit (NEB). Luciferase 
reporter constructs harboring cDNA of TNF 3′UTR (nucleotides 1,231-1,506) was 
generated by gblock synthesis (IDT) and was inserted into the psicheckTM-2 construct at 
restriction sites XhoI and NotI.  
Human embryonic kidney (HEK) 293 cells were plated at a density of 300,000 cells/well 
in 6 well plates, with Dulbecco′s Modified Eagle′s Medium (DMEM) containing 100 
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units/mL penicillin and 100 µg/mL streptomycin and 10% fetal bovine serum (FBS). The 
plates were incubated for 24 hours in a humidified 5% CO2 incubator set at 37 C. When 
the cells were 60-70% confluent each well was cotransfected with 0.25 µg 
psicheck2_TNFalpha and 0.5 µg of pcDNA3.1-His-C (empty plasmid), pcDNA3.1 TTP, 
pcDNA3.1 TTPTZF_TIS11d, or pcDNA3.1 TTP (C162S) using Dharmafect Duo protocol 
(Thermo-Scientific). Transfections were performed in triplicate. 48 hours after 
transfection, cells were harvested and Luciferase activity was monitored using a Dual-
luciferase Reporter Assay System (Promega) and normalized by the internal control 
values given by firefly luciferase. Luciferase activity was monitored in each well 3 times.  
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Chapter V: Missense mutations in the TZF 
of TIS11d affect fold and cellular localization 
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Abstract 
TIS11d is a member of the post transcriptional regulator TTP family whose 
function is to bind adenine-uracil rich elements in the 3′ UTR of many different cytokine, 
growth factor, and proto-oncogenes encoding mRNAs to regulate intracellular turnover. 
Missense mutations of TIS11d have been associated with many different types of 
leukemias in patients. Here we show that two missense mutations, P190L and D219E, 
located in the RNA binding domain (RBD) of TIS11d affect its structural flexibility 
while maintaining RNA binding activity similar to that of wild type TIS11d. However, 
while in HEK293 cells GFP tagged TIS11d is uniformly distributed in the cytoplasm, 
P190L and D219E mutants display a markedly distinct phenotype consisting of puncta 
within the cytoplasm. This result suggests that the increased flexibility of the RBD affects 
the localization of TIS11d in the cell and plays a role in disease pathogenesis.  
 
Introduction 
Cytokines and growth factors function to regulate and maintain normal growth, 
cellular differentiation and development, and tissue homeostasis189. Misregulation of 
cytokines can lead to development of autoimmune diseases and cancer pathogenesis190.  
Therefore, growth factors and cytokines and their respective signaling pathways are 
tightly regulated at the transcriptional and post-transcriptional level.   
  Several transcripts encoding immune proteins contain A-U-rich elements (AREs) 
in their 3′ untraslated regions (UTRs)191. One protein that binds to AREs is tristetraprolin 
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(TTP), the prototype of the CCCH-type zinc finger family of proteins, to promote 
degradation of the transcript.  This process provides an important mechanism for 
reducing the synthesis of key cytokines, such as tumor necrosis factor (TNF) - and 
granulocyte-macrophage colony stimulating factor (GM-CSF)75,121.  In humans, the TTP 
protein family has two other members, TIS11b and TIS11d. The RNA binding domain 
(RBD) of TIS11b and TIS11d consists of two CCCH zinc fingers (ZFs) that share a high 
degree of sequence identity to TTP (71%) and have TTP-like activity, yet neither TIS11b 
nor TIS11d can replace TTP function in TTP knockout mice, indicating that they are not 
functionally equivalent to TTP140. To date, the biological functions of TIS11d and 
TIS11b are not fully defined.  
Mutations in the TTP family that result in cancerous phenotypes in humans, 
suggesting their role in controlling proto-oncogenic mRNAs192. Breast and prostate 
cancers are characterized by their inability to express the protein TTP74. Misregulation of 
identified TTP - regulated transcripts, such as FOS, MYC, and COX-2, results in 
uncontrolled cell proliferation, insensitivity to pro-apoptotic stimuli, and 
angiogenesis84,85,193,194. Recent mice knockout experiments determine that TIS11b/d are 
required for proper thymocyte development and, when depleted, result in T-
lymphoblastic leukemia104. Leukemia in these mice is associated with overexpression of 
the transmembrane protein Notch1, which acts as an oncogenic transcription factor as it 
controls many cell fate pathways104. Further work is required to understand the TTP 
family's role in the early stages of cancer pathogenesis. The study herein focuses on two 
missense mutations, P190L and D219E, located in the RNA binding domain (RBD) of 
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TIS11d that are found in patients tissues with acute myeloid leukemia and acute 
lymphoblastic leukemia, respectively103. Despite the critical role that TTP proteins play 
in controlling normal homeostasis of the cell, little is understood of how missense 
mutations in the RBD lead to disease. To understand how these mutations affect the 
biological function of TIS11d, we used NMR and biochemical assays to characterize the 
structure and RNA binding activity of the RDB, and we collected fluorescence confocal 
images to determine the subcellular distribution. We observe that the mutations affect the 
structure and dynamics of the RDB and cause mislocalization of the protein in the cell 
that might interfere with its normal function and lead to pathogenesis. 
 
Results 
TIS11d missense mutations show ZF2 structural flexibility by NMR.  
In 2004 Wright and coworkers determined the structure of TIS11d when bound to 
the single stranded RNA sequence 5′-UUAUUUAUU-3′ (PDB code:1RGO) using NMR 
spectroscopy127. This structure depicts two folded zinc fingers where the zinc ions are 
coordinated by residues C159, C168, C174, and H178 in the first finger (ZF1) and C197, 
C206, C212, and H216 in the second finger (ZF2), respectively. The protein-RNA 
complex shows that the structure of the tandem zinc finger (TZF) domain of TIS11d is 
rather symmetrical, in that both ZF1 and ZF2 contain a short α helix (spanning residues 
160-165 in the first finger and 198-203 in the second finger) sandwiched between the first 
two zinc coordinating cysteine residues130. Additionally, both fingers contain a 310-helix 
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between the second and third cysteine coordinating resides (amino acids 171-173 in the 
first finger and 209-211 in the second finger). The two zinc fingers are held together by a 
flexible linker whose only form of secondary structure element is a 310-helix at residues 
179-183 and is involved in forming a small hydrophobic cluster with residues of the first 
finger. NMR and computational studies have shown that in the absence of RNA, the 
structure of the two zinc fingers of TIS11d is maintained although their orientation 
changes, as the linker region is highly flexible128. We sought to understand how these 
missense mutations affect the fold and of TIS11d using NMR spectroscopy.    
 
Figure 5.1: Overlay of 1H-15N HSQC spectra of TIS11d and TIS11d missense mutations that cause 
leukemia. The position of P190 (red) and D219 (cyan) are depicted in a conformation of TIS11d taken 
from an MD trajectory of TIS11d in the free state. Residues R188 and K193 that participate in the 
hydrogen bonding network with E220 are shown in gray. 15N-1H HSQC spectra overlays of TIS11d with 
P190L (right spectrum) and D219E (left spectrum) show the loss of cross-peaks from ZF2, as indicated by 
the cartoon above each 15N-1H HSQC. The dots indicate residues along the sequence with a cross-peak in 
the 15N-1H HSQC spectrum.  
The 15N-1H HSQC spectrum of the P190L and D219E mutations of TIS11d are 
missing cross-peaks from the linker and ZF2 indicating that these regions sample 
multiple states and as a consequence cross-peaks are broadened beyond detection (Figure 
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5.1). P190L mutation gave a much more pronounced change in the 15N-1H HSQC 
spectrum as all peaks from the linker and ZF2 are missing in the 15N-1H HSQC spectrum. 
Previous MD simulation work performed in our lab of wild type (WT) TIS11d showed 
that removal of RNA results in formation of hydrogen bonds between ZF1 and ZF2 and 
the C-terminal tail and linker, specifically E220 of ZF2 with K193 and R198 of the 
linker. Additionally, NMR and MD simulation studies of the mutants TIS11d-E220A and 
TIS11d-ΔD219/E220 (where D219 and E220 were deleted) showed that both mutations 
increased the flexibility of the linker region indicating that these two negative residues 
contribute to the overall stability of the structure of TIS11d TZF domain151,195. It is our 
hypothesis then that the P190L and D219E mutations disrupt the hydrogen bond network 
between ZF2 and the linker region resulting in more flexible, less structured domain. All 
together this data suggests that the stability of TIS11d ZF2 is necessary for normal cell 
growth and proliferation, and when it is mutationally disrupted it results in cancerous 
phenotypes.    
Secondary structural of WT TIS11d, and D219E and P190L mutations.  
To determine whether the secondary structure of ZF2 is perturbed by the D219E 
TIS11d mutation, we used circular dichroism (CD) spectroscopy. Unlike most proteins 
which give a signature CD spectra with minimum at 190 nm for random coil, 215 nm for 
beta sheet, and double minima at 205 and 225 nm for alpha helical structures, the TIS11d 
protein displays a small minimum at 220-240 nm which is indicative of aromatic stacking 
interactions associated with the minimal secondary structure observed for TIS11d130. 
D219E, however, does not have such a severe effect in secondary structure by CD only 
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indicates loss of peaks of the linker and ZF2 in the 15N-1H HSQC spectrum (Figure 2). 
Future work will focus on characterizing the secondary structural elements present in the 
P190L mutation, which has been shown to contain less structure than WT TIS11d as 
suggested by NMR analysis. These finding demonstrate that the accurate fold of TIS11d 
ZF2 is essential for its normal activity. Mutations that influence structural flexibility, 
such as D219E are found in leukemias genetically linked to human patients.  
 
 
 
Figure 5.2: Structural studies of D219E mutant of TIS11d. CD spectra of TIS11d wild type (gray), 
D219E (cyan) and unfolded TIS11d (red).  
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RNA binding activity of WT TIS11d, and mutants P190L and D219E are similar 
despite increased structural flexibility at ZF2  
We expected that disrupting the fold of the TZF would result in loss of RNA 
binding activity to the cognate RNA sequence, UUUUAUUUAUUUU. To determine the 
affinity of each TIS11d mutation to RNA we used a combination of electrophoretic 
 
Figure 5.3: RNA binding activity of mutant proteins binding to ARE13 by electrophoretic mobility 
shift. The ARE13 sequence is show. A plot of fraction bound RNA as a function of mutant TIS11d 
concentration is present below each gel. The fit of the Kd,app and error is given for the specific gel. 
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Figure 5.4: RNA binding activity of TIS11d mutations P190L and D219E measured by fluorescence 
polarization. Fluorescence polarization analysis of TIS11d mutations binding to ARE13 RNA. Raw 
polarization values are presented. A fit of the data is shown as well as the Kd,app and error.  
 
mobility shift assays (EMSA) (Figure 5.3) with untagged proteins, and fluorescence 
polarization (Figure 5.4) with maltose binding protein (MBP) - tagged protein constructs. 
The apparent equilibrium dissociation constants (Kd) were similar between what is 
reported for WT TIS11d in previous chapters of 9.1 ± 2 nM and D219E and P190L 
mutations of approximately 10 nM. These experiments suggest that although both 
mutations affect the structural flexibility of the TZF of TIS11d, they do not affect the 
binding affinity to the cognate RNA sequence. The high affinity measured for TIS11d 
missense mutations suggest that these proteins can still fold to form a stable complex 
with RNA, as mutations that disrupt fold of TIS11d ZF2 (such as the C212S zinc 
coordination mutation) are not RNA binding competent. The high RNA-binding affinity 
measured for these mutant proteins suggest that the mechanism by which P190L and 
D219E disrupt TIS11d wild type activity is not through RNA binding of ARE13. 
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Sub-cellular localization of WT TIS11d, mutants P190L and D219E and control 
GFP show different phenotypes in HEK293 cells.  
Since the P190L and D219E mutations in TIS11d do not affect RNA binding, we 
suppose the phenotype resulting from these mutations was directly related to the cellular 
biology. We used confocal microscopy to determine whether GFP-tagged P190L and 
D219E mutants had a different subcellular localization in HEK293 cells than the WT. It 
is important to note that the fusion protein containing a GFP tag does not alter shuttling 
of the TTP family between the nucleus and cytoplasm196. The TTP family members are 
all nucleocytoplasmic shuttling proteins, with a leucine rich LxxxLxxLxL N terminal 
nuclear export signal (NES)197. The nuclear localization signal (NLS) was mapped to the 
basic residues R134 and R137 of the linker region of the TZF196. Mutations of these  
arginines to alanines results in the mislocalization of TTP; however, RNA binding is not 
affected. Given the role the TTP linker plays in subcellular localization, we hypothesized 
that P190L and D219E may also affect localization. We use HEK293 cells for our 
experiments as they do not endogenously express TIS11d. Confocal images taken for 
 
Figure 5.5: Sub cellular localization of GFP, TIS11d, P190L and D219E. Confocal images of HEK293 
cells transiently transfected with EGFP tagged full length TIS11d, and P190L and D219E mutations. 
Subcellular localization of GFP‐labeled proteins were observed 24 hours after transfection into HEK293 
cells using fluorescence confocal microscopy.  
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HEK293 cells of GFP alone showed evenly distributed fluorescence throughout the 
cytoplasm and nucleus (Figure 5.5). Consistent with mRNA destabilizing activity of 
TIS11d, GFP-tagged TIS11d was dispersedly localized throughout the cytoplasm. In 
contrast, overexpression of D219E and P190L TIS11d mutants results in the presence of 
puncta within the cytoplasm (Figure 5.5). This data supports a mechanism by which 
single nucleotide polymorphisms within the RBD of TIS11d can affect activity by 
altering cellular localization.  
 
Conclusions and future directions:  
 We sought to understand the mode by which missense mutations in TIS11d, 
D219E and P190L, affect its folding, RNA binding activity, and subcellular localization. 
We determined that the structural flexibility, and possibly destabilization of the structure 
of ZF2 as seen with P190L, may play a role in disease pathogenesis. The structure of the 
RBD affects TIS11d localization as GFP - tagged wild type TIS11d has a disperse pattern 
in the cytoplasm of HEK293 cells; however, TIS11d P190L - and D219E - tagged GFP 
constructs localize to unidentified puncta within the cell.  
The localization into foci observed for P190L and D219E could be due to 1) stress 
granules since in response to cellular stress, unphosphorylated/active TTP is known to 
colocalize with these transient mRNA storage vesicles, or 2) processing bodies (P-
bodies)198 since when TTP is phosphorylated it is excluded from stress granules and 
released into p-bodies, the site of mRNA turnover72. However, many of the observed foci 
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are larger than what would be expected for p-body, suggesting that they may be: 1) 
aggresomes generated from misfolding TIS11d which result after overwhelming the cells 
protein degradation machinery199, or 2) autophagosomes which carry abnormal 
intracellular proteins to lysomes for degradation200. In order to fully understand how and 
why these cytoplasmic puncta are formed in TIS11d mutant variants, further studies are 
required to identify these puncta using co-immunofluorescence experiments of known 
protein target antibodies at each suspected localization site.  
Taken together, this study highlights how small changes in primary sequence of 
the essential post-transcriptional regulator TIS11d can affect its protein flexibility and 
activity, which can then manifest into disease. The cancer genomics database Cbioportal 
was used to identify frameshift and point mutations throughout TIS11d and TTP gene 
locus, which have been observed in tissues taken from leukemia patients. Interestingly, 
more mutations linked to various leukemias and cancers have been mapped throughout 
the length of TIS11d RBD in comparison to TTP, suggesting that the structural integrity 
of TIS11d is important for its functions101. Curiously, the prototype of this family, TTP, 
unlike TIS11d, always has a partially folded RBD, unless bound by RNA, and has diffuse 
cytoplasmic localization when tagged with GFP185. These results suggest that TTP and 
TIS11d have evolved to have divergent modes by which they execute cellular activities. 
Our results suggest that the appropriate folding of the RBD is coupled with the proper 
translocation of TIS11d, since mutations that affect TIS11d TZF structural integrity 
become mislocalized to cytoplasmic foci in the cell. Our lab and others have shown that 
RNA free form of TTP is partially folded and folds completely upon RNA binding, 
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which suggests a possible control mechanism of TTP/mRNA translocation and 
subsequent mRNA decay. RNA association with TTP may be required for its 
translocation into the cytoplasm for mRNA degradation. The work presented in this 
chapter warrants future experiments designed to test the extent of TZF folding on 
localization and mRNA turnover in vivo. 
 
Methods and Materials  
Expression and Purification of TIS11d, P190L and D219E: 
Cloning, Expression and Purification of the TZF of TIS11d and mutants 
The RBD of human TIS11d (residues 152-220) was synthesized by Genescript and 
cloned into the pHMTC vector between BamHI and HindIII restriction sites. TIS11d-
E220A and TIS11d- Δ D219/E220 (152-218) constructs were generated using the 
QuikChange Site-Directed Mutagenesis Kit from Stratagene. TIS11d and mutated 
constructs were expressed in BL21(DE3) E. coli competent cells.  Isotopic labeling with 
15N was performed by growing the cells in M9 enriched with 1 g of 15NH4Cl per liter.  
Carbon labeling is performed by growing cells in M9 containing 13C-glucose. The cells 
were grown at 37°C to an OD600 of 0.8 and then induced for 4 hours with 1 mM isopropyl 
β-D-1 thiogalactopyranoside (IPTG) and 0.1 mM ZnSO4 at the same temperature. 
Harvested cells were then passed through a cell disrupter in 50 ml lysis buffer containing 
50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 µM ZnOAc, 2 mM dithiothreitol (DTT) 
and 1 EDTA free Complete protease inhibitor tablet (Roche).  Lysate was centrifuged at 
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19500 RPM for 1hr at 4°C and passed through a 20 ml amylose column pre-equilibrated 
with wash buffer (50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 µM ZnOAc and 2 mM 
DTT). The column was washed with 10 column volumes of wash buffer. The protein was 
eluted with 10 mM maltose in wash buffer. The eluent was then placed over a 5 ml Hi 
TRAP Q column (GE healthcare Life Science) pre-equilibrated with the same wash 
buffer used above. The column was washed with 3 column volumes of wash buffer. The 
protein was eluted with a gradient of NaCl from 0-1 M; the peptides typically eluted at 
0.3-0.5 M NaCl. Fractions containing our protein were combined, concentrated and 
dialyzed in 50 mM Tris HCl, pH 8.0, 300 mM NaCl, 100 µM ZnOAc and 2 mM DTT in 
the presence of TEV at 1:10 ratio and left to proteolyses for 24 hours. The protein was 
further purified using a 1.6 X 60-cm Superdex-75 size exclusion column (Amersham 
Bio\sciences) equilibrated with 50 mM Tris HCl pH 7, 300 mM NaCl, 2 mM BME to 
separate the 8.5 KDa fragments. For NMR analysis fractions with TIS11d or mutant 
forms of TIS11d were buffer exchanged into 10 mM Tris pH 6.2, 20 mM KCl, 2 mM 
DTT, 0.1 mM ZnSO4.  
 
RNA binding activity measured by fluorescence polarization and EMSA 
Fluorescence Polarization (FP) RNA binding assays were performed with uncleaved 
Maltose Binding Protein (MBP) tagged protein for accurate determination of protein 
concentration via absorbance at 280 nm. Optimal binding of the TZF domains to RNA 
was measured in the presence of 10 mM Tris HCl, pH 8.0, 100 mM NaCl, 0.1 mM 
Zn(OAc)2, 0.01% IGEPAL CA630, and  2 mM DTT.  The affinities of TIS11d, TIS11D-
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E220A and TIS11d-Δ D219/E220 (152-218) for the sequence: 
5−UUUUAUUUAUUUU−3 (ARE13) were measured by direct titration of 3 nM labeled 
RNA with increasing concentrations of protein using fluorescence polarization.  
 Electrophoretic Mobility Shift Assays (EMSA), unlike FP,  RNA binding assays 
were performed with cleaved Maltose Binding Protein (MBP) tagged protein for accurate 
determination of protein concentration via absorbance at 280 nm were conducted as 
discussed previously. Optimal binding of TIS11d to RNA was measured in the presence 
of 2 mM dithiothreitol, DTT. The affinities of TIS11d, Kd (apparent) for the sequence: 5-
UUUUAUUUAUUUU-3 (ARE13), was measured by direct titration of 3 nM labeled 
RNA with increasing concentrations of TIS11d as described in Pagano et al174.  The Kd,app 
of TIS11d to ARE13 is not fit to the quadratic equation but to the quadratic equation  
𝑓 =
𝑚−𝑏
2𝑅
(𝐾𝑑 + 𝑃 + 𝑅 − √[𝐾𝑑 + 𝑃 + 𝑅]2 − 4𝑅𝑃) + 𝑏, 
 
where m and b are the maximum and base signals, Kd is the dissociation constant, and P 
and R are the concentrations of protein and labeled RNA in the sample, respectively. 
 
NMR spectroscopy  
Folding of TIS11d and TIS11d P190L and D21E mutations were monitored via NMR 
spectroscopy. 15N-1H HSQC spectra were collected at 298 K for each chimera. All NMR 
triple-resonance and 15N-1H HSQC experiments were collected on a Varian Inova 
spectrometer operating at 600 MHz equipped with a triple-resonance cold probe. The 
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temperature was calibrated using a sample of 100% methanol. Data processing was 
performed using NMRPipe 145 and Sparky software146. 
 
CD spectroscopy 
Far-UV circular dichroism (CD) spectra were recorded for D219E (60 M) and TIS11d 
(18 M) in 50 mM HEPES pH 7.0, 20 mM KCl and 1 mM TCEP using a Jasco-810 
spectropolarimeter (Jasco Inc., Easton, MD). Curves were monitored from 200-260 nm in 
a 0.1 cm path length quartz cuvette using a scan rate of 20 nm min-1 and a response time 
of 8 s. The sample temperature for all CD measurements was maintained at 293 K.  
 
Confocal Microscopy 
The pDEST53 and pDEST53TIS11d mammalian expression construct were made using 
the Gateway cloning system. pDEST53D219E and pDEST53P190L were then generated 
using Q5-mutagenesis kit (NEB). Human embryonic kidney (HEK) 293 cells were plated 
at a density of 300,000 cells/well in glass bottom plates (MatTek), with Dulbecco′s 
Modified Eagle′s Medium (DMEM) containing 100 units/mL penicillin and 100 µg/mL 
streptomycin and 10% fetal bovine serum (FBS). The plates were incubated for 24 hours 
in a humidified 5% CO2 incubator set at 37 C. When the cells were 60-70% confluent 
each were transiently transfected with 1 µg of pcDNA3.1-His-C (empty plasmid), 
pcDNA3.1 TTP, pcDNA3.1 TTPTZF_TIS11d, or pcDNA3.1 TTP (C162S) using 
lipofectamine 2000 (Sigma). 48 hours after transfection, cells were imaged via 
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fluorescence confocal microscopy using a Leica TCS SP5 confocal Scanning microscope 
at UMass Medical School.  
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Chapter VI: Discussion 
  
 
 
 139 
Tristetraprolin (TTP) and its family members, TIS11d and TIS11b, are essential 
RBPs, known to regulate gene expression in order to maintain cellular homeostasis. 
Dysregulation of TTP expression and function is associated with chronic inflammation 
and cancer due to the aberrant expression of tightly-regulated genes. Many cancer cells 
have shown decreased expression levels of TTP, which has arisen as a common 
prognostic indicator for breast cancer201. Understanding how TTP, and its family 
members, bind to and regulate their mRNA targets will help define their role in human 
pathology.  
Identifying TIS11d Targets 
In Chapter II, we discovered the role primary and secondary structural elements in 
the TTP family of proteins plays on their target mRNA binding and selectivity.  
Explicitly, we found, that the post-transcriptional RNA binding proteins (RBPs), TTP and 
TIS11d, have different RNA sequence specificities despite sharing large primary 
sequence identity. This finding exemplifies how changes in protein sequence can 
influence the protein structure and propagate to differences in RNA binding specificity. 
By substituting adenine nucleotides for uridines in the canonical 3'-UTR sequence, we 
identified the RNA specificity determinants required by TTP and TIS11d. These results 
highlighted the need for identifying RNA sequence determinants in the regulation of 
RNA-binding. Peak intensity differences in the 15N-1H heteronuclear single quantum 
coherence (HSQC) spectrum mapped to the adenine coordination sites of the TZF domain 
suggested degeneracy in TTP RNA binding that was not observed with TIS11d – 
consistent with a more “relaxed” binding structure. Comparing the binding affinities of 
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TTP and TIS11d for various lengths of RNA targets by fluorescence polarization and 
NMR spectroscopy established that TTP specifically coordinates an adenine nucleotide at 
residues just preceding ZF1, whereas TIS11d was not found to require this same specific 
RNA sequence. We concluded that the difference in specificity of TTP for the 5'UAUU3' 
half site at ZF1 is due to differences in TIS11d and TTP RBD stability. TTP, unlike 
TIS11d, needs RNA to stably fold ZF2, as described through an induced-fit mechanism. 
Specifically, we determined that an extra hydrogen bond formed between TTP ZF1 and 
RNA by residue E107, is required for TTP-RNA interaction where it serves as an anchor 
for ZF2 binding/folding on the RNA. The ZF2 of TIS11d is already folded in its ligand-
free state and therefore does not require a stable interaction between ZF1 and RNA to 
fold. Because TIS11d lacks the same adenine coordination constraint in ZF1 as TTP, this 
may allow for it to be more promiscuous in binding biological targets. A key gap in our 
understanding is whether this mechanism is applicable in other RBPs, specifically 
proteins containing one or more CCCH-type zinc finger domains.  
With the confirmation of ARE13 (5 U̍UAUUUAUU3 ̍) and uridine substituted 
(5 ̍UUUUUUAUU3 ,̍ 5 ̍UUAUUUUUU3 ̍ and 5 ̍UUUUUUUUU3 ̍) binding sites, several 
approaches can be implemented to identify “true” biologically relevant mRNA targets of 
TIS11d from a complex pool of cellular transcripts. Determining TIS11d targets with the 
strict criterion of measuring in vivo mRNA stabilization in cells derived from TIS11d 
knockout mice is a time-intensive process. Bioinformatics has made the ability to predict 
potential targets more time efficient; however, this method requires confirmation of all 
predictions and is limited to identification only.  Fortunately, genome-wide approaches 
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allow for the identification of thousands of target transcripts simultaneously in response 
to altered levels of TIS11d expression. Microarray profiling identified 250 of 40,000 
probed 3 ̍ UTRs in TTP knockout mice fibroblasts that demonstrated increased RNA 
lifetimes compared to wild-type fibroblasts after stimulation with epithelial growth factor 
for various time intervals followed by treatment with actinomycin D to halt additional 
mRNA synthesis98. This study was encouraging as Northern blots confirmed TTPs 
interaction with these 3’UTRs; showing the utility of genome-wide analyses to study 
mRNA decay.  However, targets that did not strictly conform to the 5’UUAUUUAUU3’ 
sequence, may have been missed during the bioinformatics analysis which make it an 
imperfect strategy for RBPs that bind with relaxed specificity as seen with TIS11d. A 
more recent study using RNA immunoprecipitation and microarray analysis (RIP)-Chip 
on TTP to compare wild-type and TTP-knockout embryonic fibroblasts identified 137 
full-length transcripts that are associated with TTP77. This approach is advantageous over 
traditional microarray because it can identify sequence elements that are enriched among 
TTP-associated mRNAs. Alternatively, TTP directly-associated mRNA targets can be 
identified utilizing Photoactivatable-Ribonucleoside-Enhanced Crosslinking and 
Immunoprecipitation (PAR-Clip). The exact position of the crosslink can be determined 
by mutations in the cDNA, where base pairs of 4-thiouridine are made only with 
guanidine, incorporating a T to C mutation in the cDNA library that can be identified 
using deep sequencing202. Using this technique in HEK cells, 5-fold more mRNAs were 
identified than by the previously described techniques99. Combining PAR-Clip with 
secondary screens to demonstrate biological relevance will allow the identification of 
 
 
 142 
other targets of TIS11d. These targets can then be tested for interaction with TTP by 
measuring changes in RNA stability, translational activity (repression), differences in 
subcellular distribution (P-bodies), or global phenotypes (immunocompromised mice), 
etc, to be classified as truly biologically relevant.  
Understanding the physical forces that drive TTP and TIS11d discrimination for 
their unique mRNA targets is critical for understanding how they regulate RNA turnover 
in the cell. Many other factors bind the TTP family of proteins for their 
activation/inactivation, localization, and mRNA degradation activity.  Whether RNA 
induced structural differences that result in the TTP family biological functions is still a 
mystery and will be an exciting area of research in the future. 
Leveraging our knowledge on RNA recognition for therapeutic design 
Engineering zinc fingers to bind a particular RNA target is an active goal in 
developing therapeutics. Since CCCH RBDs are small, uncomplicated protein domains 
RNA binding specificity is dictated mainly through their primary sequence. Here, we 
highlight how tertiary structure may also play a role in determining specificity. Therefore, 
the field must also take into consideration the final folded structure of the CCCH motif 
when designing new therapeutics.  
The results in Chapter II, provides insight into other proteins containing CCCH-
type zinc fingers and the role played by primary sequence in determining RNA 
specificity. Studies done by our lab and others demonstrate that the TZF domain of the C. 
elegans protein MEX-5 binds to uridine stretches high affinity and low specificity. In 
contrast, the mammalian protein TIS11d binds specifically to 5’UUUUAUUUAUUUU’3 
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with high affinity. The relaxed binding specificity seen in MEX-5 is attributed to the 
Arg/Lys (R274/K318) in the fifth residue (X) of the highly conserved R(K)YKTXL motif 
preceding each zinc finger. In mammals, the fifth residue (X) is always a glutamate; 
whereas in C.elegans, this position is less uniform203. Indeed, TIS11d mutations at this 
position are seen in patients with various forms of cancer highlighting the importance of 
this specific residue in RNA binding.  To study the role this residue plays in RNA 
binding, we generated the equivalent mutations in TTP and TIS11d, E107R/E145K and 
E157R/E195K, respectively and found that mutations of the R(K)YKTEL in ZF1 are 
detrimental to TIS11d (TTP) RNA binding, while the mutations in ZF2 do not negatively 
affect the binding affinity. These findings exemplifies the challenges associated with 
defining the recognition sequence for all CCCH TZFs, since what is known about the 
TZF fold and specificity for one CCCH member may not hold true for all CCCH 
members.   
Tumor suppressor therapies though direct protein injection  
The loss of TTP expression in cancer cell lines is thought to contribute to 
tumorigenesis. Recently (2010) researchers were able to successfully inject a 
recombinant form of the purified TTP family member, TIS11b, into adrenal glands of 
immunodeficient mice and nude mice with subcutaneous cell carcinomas using a poly-
arginine tag (R9) fused to its N terminus204. R9-TIS11b treated mice showed decrease 
angiogenesis and tumor growth as consequence of reduced VEGF mRNA levels, 
suggesting that using a similar approach to increase TTP protein levels in human cancer 
cells could be a viable therapeutic technique. Although TTP family members seem to be 
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excellent targets for antitumor therapies, their off target effects have not been examined. 
Identifying the specificity determinants for the TTP family will be useful in developing 
therapies for immune disease and cancers that have as few off target effects as possible. 
Furthermore, understanding what transcripts are regulated by which protein of a family 
will allow us to evaluate other genes that may be therapeutic targets of TTP family 
injection therapies.  
Molecular basis for disease 
The accurate post-transcriptional regulation of genes by regulatory RNA-binding 
proteins requires the ability to recognize specific transcripts from a complex pool of 
cellular mRNAs. This is accomplished through stable sequence- and structure- specific 
interactions between the RNA binding proteins and their target mRNAs. The RNA 
binding protein tristetraprolin (TTP), and its homologues TIS11b and TIS11d, are 
required for post-transcriptional repression of many different genes associated with 
inflammation and cancer initiation/progression in mammals. TTP family members 
mediate post-transcriptional repression by binding mRNA targets to promote their 
degradation. Misregulation of TTP directed mRNA degradation results in a wide array of 
host-cellular responses including acute inflammatory responses to harmful stimuli. TTP-
deficient mice suffer from a systematic inflammatory syndrome characterized by arthritis, 
autoimmune disorders, and myeloid hyperplasia associated with over-expression of the 
proinflammatory cytokine TNFα. Therefore, identifying mutations in TTP that 
increase/decrease its activity can be used to develop therapeutics for inhibiting mRNA 
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over-biosynthesis which causes toxic accumulation of cytokines and growth factors that 
lead to chronic inflammation and cancer.  
Developing therapeutics to increase TTP activity by folding its RBD  
In Chapter III of this thesis, we examined the structural differences observed 
between the highly identical (72%) RBDs of TTP and TIS11d. NMR data collected for 
their RBDs determined that TTP is partially unfolded and TIS11d is folded in their RNA 
free state. NMR and binding assay of chimeric proteins of the TZF domains of TTP and 
TIS11d established that three residues located at the C-terminal end of the -helix 
determine the structure of TZF domain. Using a reporter assay where luciferase 
expression was under control of the TNFα 3’UTR, we observed that mRNA destabilizing 
activity of TTP was increased when the partially disordered TZF domain of TTP was 
replaced with the fully structured domain of TIS11d. These results demonstrate that the 
degree of structure present in the TZF domain directly affects the function of the protein 
in the cell and suggests that protein activity is modulated through its structure. 
Stabilization of the TTP RBD occurs upon binding to RNA, but also occurs upon 
zinc coordination. This stabilization may play a role in the cellular localization and 
mRNA degradation activity of TTP. Analysis of the amino acid sequences of TIS11d and 
TTP from 100 vertebrate species suggests that the TZF domain of TIS11d is always folds 
as the three -helical residues, histidine-threonine-isoleucine, sufficient to stabilize the 
structure of ZF2, are strictly conserved. In TTP, however, the corresponding three 
residues, tyrosine-leucine-glutamine, which are associated with the observed disorder in 
the TZF domain, are only conserved in mammals. In fish and birds these three residues 
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are the same as in TIS11d, suggesting that the TZF domain of TTP is possibly folded in 
these vertebrates. Comparative genomics suggests that the activity regulation of TTP 
through its structure has evolved more recently in mammals. 
 
 
Because zinc is a critical mediator of TTP-RNA-binding activity, we sought to 
investigate the molecular mechanism by which TTP interacts with zinc to form a stable 
protein-RNA complex. Figure 6.1 depicts the possible mechanisms of TTP ZF2 binding 
in the presence of zinc and RNA. Three possible scenarios exist for the mechanism of 
TTP folding in the presence of both cofactors: 1) both RNA and zinc bind simultaneously 
to TTP to form a stable RNA bound complex; 2) zinc binds to fold ZF2 after which RNA 
can bind; 3) RNA binding precedes zinc binding. Previous experiments by our lab and 
others on a TTP mutant (C162S), which cannot coordinate zinc, was found to not bind 
RNA, thus eliminating the third scenario as a possible mechanism for TTP zinc and RNA 
binding. In order to determine whether zinc and RNA binding is a concerted versus 
Figure 6.1: Mechanisms of RNA binding. Schematic representation of the three 
possible scenarios for the mechanism of TTP folding in the presence of RNA and 
zinc. (Top ) Both RNA and zinc bind simultaneously to TTP to form a stable RNA 
bound complex; (Middle) zinc binds to fold ZF2 after which RNA can bind; (Bottom) 
RNA binding precedes zinc binding. 
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stepwise reaction process, other biophysical techniques must be employed. One such 
technique is time - resolved FRET to look at the differences between association with 
RNA binding of ZF1 and ZF2 since the FRET excited state decays will differ depending 
on the mechanism as the probes will have different distances in the folded and unfolded 
states. If ZF1 and ZF2 are folded prior to RNA binding, as in scenario number 2, their 
FRET associations will be the same. If ZF1 needs to fold before RNA can associate, as in 
scenario number 1, then their FRET will be different.  
Given that mRNA turnover activity of TTP is enhanced when its partially 
disordered TZF domain is substituted with the fully structured domain of TIS11d and that 
when the stable folded zinc finger of TIS11d is disrupted it results in disease, future 
studies must focus on structure based design to identify potential locations for small 
molecule binding on the partially folded TZF of TTP and misfolded variants of TIS11d. 
HSQC NMR-based screening would be a powerful way to identify small molecules that 
can bind and fold TTP. Other high throughput approaches, such as intrinsic tyrosine 
fluorescence may not allow for the resolution required to couple folding to compound 
binding. Other methods, such as FRET, that use probes to look at secondary structure 
changes may also present an issue since they require re-engineering the native protein, 
which could alter the limited secondary structure available. Screening many different 
compound libraries could result in the identification of several putative compounds to 
stabilize ZF2. After defining which compounds bind to induce a fully folded TTP TZF, a 
more rational based design/optimization of these therapeutics could be explored. Using 
our biophysical understanding of the partially folded state of TTP and what specific 
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interactions are necessary for it to fold and function, molecular dynamics simulations and 
modeling techniques can be used to optimize the structure and functional groups of our 
putative compounds to enhance binding affinity.   
 Molecules that stabilize the TTP family RBD fold could be further screened 
utilizing the luciferase reporter system developed by our lab and discussed above. 
Through the direct measure of enhanced luciferase turnover we can control for issues 
associated with drug delivery to target TTP folding in the nucleus. Furthermore, the 
consequences of induced TTP folding upon binding of these small molecules can be 
tested in mice. Recent advancements in gene editing techniques would allow us to even 
make changes to TTP in vivo. We could use the CRISPER/Cas9 in TTP KO mice, which 
suffer from systematic inflammatory syndrome, to see if targeted changes to TTP, such as 
replacing the unfolded YLQ motif with the folded HTI motif from TIS11d, will rescue 
the mouse phenotype by allowing  a more rapid turnover of the toxic TNF-α cytokine 
mRNA. 
Understanding how the structure of the RBD affects the rest of the TTP sequence 
Chapter IV investigates the relationship between the structure and function of the 
TIS11d TZF. Studies using wild-type and disease-associated mutations, P190L and 
D219E, demonstrated differences in structural flexibility of the RBD of TIS11d.  In 
contrast, both mutations still bound similarly to the cognate RNA sequence. Expression 
analysis in HEK293 cells using GFP-tagged construct showed TIS11d distributed 
throughout the cytoplasm. However, P190L and D219E mutants display puncta within 
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the cytoplasm. These results suggest that the folding and structure of the RBD can affect 
the regulation and localization of TIS11d in cell culture models.  
 In this thesis I mainly describe the biochemical and biophysical studies 
characterizing the RBD of the TTP family; however, it is important to note that the N-and 
C-terminal domains, which are predicted to be highly disordered, contain important sites 
for the temporal and spatial regulation of the activity of the TTP family. For example, the 
translocation of the TTP/RNA complex is achieved through its interaction with many 
protein partners, including the exportin CRM1, which contains an N terminal 
hydrophobic LxxxLxxLxL sequence known as the nuclear export signal (NES)197. This is 
significant as mRNAs bound by TTP are transported to stress granules where they are 
sequestered from translation machinery or to processing bodies (p-bodies) where they are 
degraded by various cellular mechanisms. Both p-bodies and stress granules are 
important for the repression of gene expression.   
 Understanding how the structure of the RBD affects the rest of the TTP sequence 
is important to understand how protein-RNA interactions may affect TTP activity in the 
cell. Interestingly, truncation experiments mapped the TTP nuclear localization signal 
(NLS) to the interfinger linker region of its TZF/RBD. Further mutational analysis 
demonstrated that the nuclear transport proteins Importin α/β bind to the basic residues 
R134 and R137 of the linker region of the TZF185. Mutations of these residues to alanines 
results in the mislocalization of TTP. The fact that the NLS of TTP is also contained in its 
RBD suggests that the RNA target may play a role in directing TTP into and out of the 
nucleus. When considered with our research showing that RNA is necessary for TTP 
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folding, this suggests that a fully-folded TTP may be required to ensure the proper 
cellular localization of TTP.  
Biophysical characterization of TTP in complex with other protein-protein 
interactomes, such as14-3-3 chaperone proteins or importin α/β, in the presence and 
absence of RNA will allow us to identify the role played by RNA in facilitating TTP 
protein associations in vivo. Since the structures of 14-3-3 chaperone proteins and 
importin α/β have been solved by x-ray crystallography, co-crystallizing TTP in its RNA 
free and bound states may provide insight into how RNA stabilizes TTP protein-protein 
interactions.  Additional insights may come from gel mobility shift assays to determine 
how the addition of RNA enhances TTP-protein complex formation.  
Additionally, the ability of TTP to target transcripts for rapid cytoplasmic 
degradation is regulated via its hyper-phosphorylation at residues S60 and S186, which 
are directly adjacent to the RBD, by MAPK-AP kinase-2 (MK2). A possible explanation 
is that phosphorylation of TTP results in its interaction with the chaperone 14-3-3 dimer 
complex allowing it to be trafficked into p-bodies. TTP interaction with 14-3-3 protein is 
thought to preclude CAF1 association with the CCR4-NOT1 complex in order to halt 
mRNA degradation. Dephosphorylation of TTP by protein phosphatase 2A (PP2A) 
releases the 14-3-3 proteins and restores mRNA degradation activity. The molecular 
mechanism by which TTP is recognized by the 14-3-3 dimer complex is poorly 
understood and many unanswered questions remain. Does phosphorylation stabilize the 
second zinc finger to allow the binding of the 14-3-3 complex? Answering this and other 
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questions in order to understand how TTP makes critical protein-protein and protein-
RNA interactions within the cell will further aid in therapeutic design.  
Thesis Summary 
The focus of these studies was to understand how the tristetraprolin (TTP) family 
of proteins regulates RNA at the molecular level. Particular attention was given to 
determining how the structure of their RNA binding domain (RBD) may affect their 
activity in the cell. Biophysical studies on two members of this family, TTP and TIS11d, 
have shown that the RBD of TTP is only partially-folded in the absence of RNA, unlike 
its homologous family member TIS11d, which is fully folded. A multidisciplinary 
approach was employed to identify the residues responsible for the structural diﬀerences 
observed for TIS11d and TTP as well as to understand the relationship between their 
differences in structure, RNA-binding specificity, and cellular activity. Altogether, we 
conclude that the extent of TZF folding in the TTP family is important for differential 
RNA recognition, mRNA turnover, and protein localization in vivo. Further work to 
understand how TTP partially folded state influences its activity could be leveraged for 
future therapeutic design.  
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